-
1Academic Journal
Authors: S. B. Petrov, K. A. Nikulina, A. V. Arnautov, S. A. Reva, С. Б. Петров, К. А. Никулина, А. В. Арнаутов, С. А. Рева
Contributors: The study was not sponsored, Исследование не имело спонсорской поддержки
Source: Urology Herald; Том 12, № 6 (2024); 89-93 ; Вестник урологии; Том 12, № 6 (2024); 89-93 ; 2308-6424 ; 10.21886/2308-6424-2024-12-6
Subject Terms: цистэктомия, transversus abdominis plane block, oncourology, multimodal postoperative pain treatment, TAP-block, postoperative pain syndrome, nephrectomy, prostatectomy, cystectomy, блокада поперечного пространства живота, онкоурология, мультимодальное послеоперационное лечение боли, TAP-блокада, послеоперационный болевой синдром, нефрэктомия, простатэктомия
File Description: application/pdf
Relation: https://www.urovest.ru/jour/article/view/985/616; Tran DQ, Bravo D, Leurcharusmee P, Neal JM. Transversus Abdominis Plane Block : A Narrative Review. Anesthesiology. 2019;131(5):1166-1190. DOI:10.1097/ALN.0000000000002842; Tsai HC, Yoshida T, Chuang TY, Yang SF, Chang CC, Yao HY, Tai YT, Lin JA, Chen KY. Transversus Abdominis Plane Block : An Updated Review of Anatomy and Techniques. Biomed Res Int. 2017;2017:8284363. DOI:10.1155/2017/8284363; Rogers T, Bhat KRS, Moschovas M, Onol F, Jenson C, Roof S, Gallo N, Sandri M, Gallo B, Patel V. Use of transversus abdominis plane block to decrease pain scores and narcotic use following robot-assisted laparoscopic prostatectomy. J Robot Surg. 2021;15(1):81-86. DOI:10.1007/s11701-020-01064-9; Lemoine A, Witdouck A, Beloeil H, Bonnet F; PROSPECT Working Group Of The European Society Of Regional Anaesthesia And Pain Therapy (ESRA). PROSPECT guidelines update for evidence-based pain management after prostatectomy for cancer. Anaesth Crit Care Pain Med. 2021;40(4):100922. DOI:10.1016/j.accpm.2021.100922; Dal Moro F, Aiello L, Pavarin P, Zattoni F. Ultrasound-guided transversus abdominis plane block (US-TAPb) for robot-assisted radical prostatectomy: a novel ‘4-point’ technique-results of a prospective, randomized study. J Robot Surg. 2019;13(1):147-151. Erratum in: J Robot Surg. 2019;13(1):153-154. DOI:10.1007/s11701-018-0858-6; Cacciamani GE, Menestrina N, Pirozzi M, Tafuri A, Corsi P, De Marchi D, Inverardi D, Processali T, Trabacchin N, De Michele M, Sebben M, Cerruto MA, De Marco V, Migliorini F, Porcaro AB, Artibani W. Impact of Combination of Local Anesthetic Wounds Infiltration and Ultrasound Transversus Abdominal Plane Block in Patients Undergoing Robot-Assisted Radical Prostatectomy: Perioperative Results of a Double-Blind Randomized Controlled Trial. J Endourol. 2019;33(4):295-301. DOI:10.1089/end.2018.0761; Taninishi H, Matsusaki T, Morimatsu H. Transversus Abdominis Plane Block Reduced Early Postoperative Pain after Robot-assisted Prostatectomy: a Randomized Controlled Trial. Sci Rep. 2020;10(1):3761. DOI:10.1038/s41598-020-60687-y; Johns N, O’Neill S, Ventham NT, Barron F, Brady RR, Daniel T. Clinical effectiveness of transversus abdominis plane (TAP) block in abdominal surgery : a systematic review and meta-analysis. Colorectal Dis. 2012;14(10):e635-42. DOI:10.1111/j.1463-1318.2012.03104.x; Matulewicz RS, Patel M, Jordan BJ, Morano J, Frainey B, Bhanji Y, Bux M, Nader A, Kundu SD, Meeks JJ. Transversus Abdominis Plane Blockade as Part of a Multimodal Postoperative Analgesia Plan in Patients Undergoing Radical Cystectomy. Bladder Cancer. 2018;4(2):161-167. DOI:10.3233/BLC-170157; Refugia JM, Thakker PU, Roebuck E, Brownstead HA, Rodriguez AR, Tsivian M. Surgeon-administered regional nerve blocks during radical cystectomy: a feasibility study. Int Urol Nephrol. 2024;56(7):2227-2234. DOI:10.1007/s11255-023-03939-w; Faraj KS, Edmonds VS, Snider SL, Bunn WD, Tyson MD. Timing of perioperative transversus abdominis plane block at the time of radical cystectomy does not affect perioperative outcomes. Int Urol Nephrol. 2021;53(10):2019-2025. DOI:10.1007/s11255-021-02872-0; Roebuck E, Beano H, Robinson M, Edwards D, Worrilow WM, Sinks A, Gaston KE, Clark PE, Riggs SB. Surgeon-administered Transversus Abdominis Plane (TAP) Block is Associated With Decreased Opioid Usage and Length of Stay Following Radical Cystectomy. Urology. 2022;161:135-141. DOI:10.1016/j.urology.2021.11.023; Taha T, Sionov BV, Rosenberg P, Stein A, Tsivian M, Sidi A, Tsivian A. Pain Control after Laparoscopic Radical Prostatectomy: Comparison between Unilateral Transversus Abdominis Plane Block and Wound Infiltration. Urol Int. 2019;103(1):19-24. DOI:10.1159/000500744; Civitella A, Prata F, Papalia R, Citriniti V, Tuzzolo P, Pascarella G, Forastiere EMA, Ragusa A, Tedesco F, Prata SM, Anceschi U, Simone G, Muto G, Scarpa RM, Cataldo R. Laparoscopic versus Ultrasound-Guided Transversus Abdominis Plane Block for Postoperative Analgesia Management after Radical Prostatectomy: Results from a Single Center Study. J Pers Med. 2023;13(12):1634. DOI:10.3390/jpm13121634; Tejedor A, Deiros C, García M, Vendrell M, Gómez N, Gómez E, Masdeu J. Comparison between epidural technique and mid-axillary ultrasound-guided TAP block for postoperative analgesia of laparoscopic radical prostatectomy: a quasi-randomized clinical trial. Braz J Anesthesiol. 2022;72(2):253-260. DOI:10.1016/j.bjane.2021.03.021; Maquoi I, Joris JL, Dresse C, Vandenbosch S, Venneman I, Brichant JF, Hans GA. Transversus abdominis plane block or intravenous lignocaine in open prostate surgery: a randomized controlled trial. Acta Anaesthesiol Scand. 2016;60(10):1453-1460. DOI:10.1111/aas.12773; https://www.urovest.ru/jour/article/view/985
-
2Academic Journal
Authors: S. A. Kuznetsov, V. V. Sizonov, I. I. Belousov, A. S. Podrezova, С. А. Кузнецов, В. В. Сизонов, И. И. Белоусов, А. С. Подрезова
Contributors: The study was not sponsored, Исследование не имело спонсорской поддержки
Source: Urology Herald; Том 12, № 6 (2024); 59-66 ; Вестник урологии; Том 12, № 6 (2024); 59-66 ; 2308-6424 ; 10.21886/2308-6424-2024-12-6
Subject Terms: радикальная нефрэктомия, renal cell carcinoma, partial nephrectomy, radical nephrectomy, почечно-клеточный рак, резекция почки
File Description: application/pdf
Relation: https://www.urovest.ru/jour/article/view/981/612; Calandrini C, Schutgens F, Oka R, Margaritis T, Candelli T, Mathijsen L, Ammerlaan C, van Ineveld RL, Derakhshan S, de Haan S, Dolman E, Lijnzaad P, Custers L, Begthel H, Kerstens HHD, Visser LL, Rookmaaker M, Verhaar M, Tytgat GAM, Kemmeren P, de Krijger RR, Al-Saadi R, Pritchard-Jones K, Kool M, Rios AC, van den Heuvel-Eibrink MM, Molenaar JJ, van Boxtel R, Holstege FCP, Clevers H, Drost J. An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity. Nat Commun. 2020;11(1):1310. DOI:10.1038/s41467-020-15155-6; Brok J, Treger TD, Gooskens SL, van den Heuvel-Eibrink MM, Pritchard-Jones K. Biology and treatment of renal tumours in childhood. Eur J Cancer. 2016;68:179-195. DOI:10.1016/j.ejca.2016.09.005; Cajaiba MM, Dyer LM, Geller JI, Jennings LJ, George D, Kirschmann D, Rohan SM, Cost NG, Khanna G, Mullen EA, Dome JS, Fernandez CV, Perlman EJ. The classification of pediatric and young adult renal cell carcinomas registered on the children’s oncology group (COG) protocol AREN03B2 after focused genetic testing. Cancer. 2018;124(16):3381-3389. DOI:10.1002/cncr.31578; Ginsburg KB, Johnson K, Moldovan T, Peabody H, Qi J, Dunn RL, Rogers C, Weizer A, Kaul S, Johnson A, Traver M, Lane BR; Michigan Urological Surgery Improvement Collaborative. A Statewide Quality Improvement Collaborative’s Adherence to the 2017 American Urological Association Guidelines Regarding Initial Evaluation of Patients With Clinical T1 Renal Masses. Urology. 2021;158:117-124. DOI:10.1016/j.urology.2021.08.036; Schieda N, Vakili M, Dilauro M, Hodgdon T, Flood TA, Shabana WM. Solid Renal Cell Carcinoma Measuring Water Attenuation (-10 to 20 HU) on Unenhanced CT. AJR Am J Roentgenol. 2015;205(6):1215-1221. Erratum in: AJR Am J Roentgenol. 2016;206(4):901. DOI:10.2214/AJR.15.14554.; Gobara A, Yoshizako T, Yoshida R, Katsube T, Ishikura Y, Kamimura T, Kaji Y. Radiological Features of T1a Renal Cell Carcinoma on Axial Unenhanced Computed Tomography. Cureus. 2023;15(3):e36881. DOI:10.7759/cureus.36881; Jonisch AI, Rubinowitz AN, Mutalik PG, Israel GM. Can high-attenuation renal cysts be differentiated from renal cell carcinoma at unenhanced CT? Radiology. 2007;243(2):445-450. DOI:10.1148/radiol.2432060559; Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S, Fernández-Pello S, Giles RH, Hofmann F, Hora M, Klatte T, Kuusk T, Lam TB, Marconi L, Powles T, Tahbaz R, Volpe A, Bex A. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. 2022;82(4):399-410. DOI:10.1016/j.eururo.2022.03.006; Burnand K, Roberts A, Bouty A, Nightingale M, Campbell M, Heloury Y. Laparoscopic nephrectomy for Wilms’ tumor: Can we expand on the current SIOP criteria? J Pediatr Urol. 2018;14(3):253.e1-253.e8. DOI:10.1016/j.jpurol.2018.01.005; Kim SP, Murad MH, Thompson RH, Boorjian SA, Weight CJ, Han LC, Erwin PJ, Costello BA, Chow GK, Leibovich BC. Comparative Effectiveness for Survival and Renal Function of Partial and Radical Nephrectomy for Localized Renal Tumors : A Systematic Review and Meta-Analysis. J Urol. 2012:S0022-5347(12)05254-8. Epub ahead of print. DOI:10.1016/j.juro.2012.10.026; Indolfi P, Terenziani M, Casale F, Carli M, Bisogno G, Schiavetti A, Mancini A, Rondelli R, Pession A, Jenkner A, Pierani P, Tamaro P, De Bernardi B, Ferrari A, Santoro N, Giuliano M, Cecchetto G, Piva L, Surico G, Di Tullio MT. Renal cell carcinoma in children: a clinicopathologic study. J Clin Oncol. 2003;21(3):530-535. DOI:10.1200/JCO.2003.02.072; Indolfi P, Bisogno G, Cecchetto G, Spreafico F, De Salvo GL, Collini P, Jenkner A, Inserra A, Schiavetti A, di Martino M, Casale F. Local lymph node involvement in pediatric renal cell carcinoma: a report from the Italian TREP project. Pediatr Blood Cancer. 2008;51(4):475-478. DOI:10.1002/pbc.21652; Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med. 1996;335(12):865-875. DOI:10.1056/NEJM199609193351207; Geller JI, Cost NG, Chi YY, Tornwall B, Cajaiba M, Perlman EJ, Kim Y, Mullen EA, Glick RD, Khanna G, Daw NC, Ehrlich P, Fernandez CV, Dome JS; Children’s Oncology Group (COG) Renal Tumor Committee. A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children’s Oncology Group AREN0321 study. Cancer. 2020;126(23):5156-5164. DOI:10.1002/cncr.33173; Abdellah A, Selma K, Elamin M, Asmae T, Lamia R, Abderrahmane M, Sanaa el M, Hanan E, Tayeb K, Noureddine B. Renal cell carcinoma in children: case report and literature review. Pan Afr Med J. 2015;20:84. DOI:10.11604/pamj.2015.20.84.5791; https://www.urovest.ru/jour/article/view/981
-
3Academic Journal
Authors: Romanova, A. S., Vishneva, E. M., Романова, А. С., Вишнева, Е. М.
Source: Сборник статей
Subject Terms: CHRONIC KIDNEY DISEASE, MYOCARDIAL INFARCTION, HYPERTENSION, NEPHRECTOMY, ХРОНИЧЕСКАЯ БОЛЕЗНЬ ПОЧЕК|ИНФАРКТ МИОКАРДА|ГИПЕРТОНИЧЕСКАЯ БОЛЕЗНЬ, НЕФРЭКТОМИЯ
File Description: application/pdf
Relation: Актуальные вопросы современной медицинской науки и здравоохранения : Сборник статей IX Международной научно-практической конференции молодых ученых и студентов, 17-18 апреля 2024 г. Т. 1.; http://elib.usma.ru/handle/usma/21200
Availability: http://elib.usma.ru/handle/usma/21200
-
4Academic Journal
Authors: P. M. Kayumova, Sh. I. Giyasov, M. B. Krasnenkova, A. N. Musabaev, П. М. Каюмова, Ш. И. Гиясов, М. Б. Красненкова, А. Н. Мусабаев
Source: Urology Herald; Том 12, № 1 (2024); 36-44 ; Вестник урологии; Том 12, № 1 (2024); 36-44 ; 2308-6424 ; 10.21886/2308-6424-2024-12-1
Subject Terms: лечение боли, anti-inflammatory agents, non-steroidal, Erector Spinae Plane (ESP) block, nephrectomy, postoperative pain, pain management, нестероидные противовоспалительные средства, блокады мышцы, выпрямляющей спину / Erector Spinae Plane (ESP) block, нефрэктомия, послеоперационная боль
File Description: application/pdf
Relation: https://www.urovest.ru/jour/article/view/828/532; Акилов Ф.А., Гиясов Ш.И. Анализ причин, частоты и тяжести острого осложнённого пиелонефрита при эндоскопической хирургии уролитиаза. Вестник урологии. 2017;5(4):5-12. DOI:10.21886/2308-6424-2017-5-4-5-12; Мирзамухамедов А.Г., Каримов Ш.И, Азизов С.З. Оперативные доступы к органам забрюшинного пространства. Монография. Ташкент; 1994.; Mayor G, Zingg EJ: Urologische Operationen, Atlas zur Indikation Technik und Nachbehandlung. Stuttgart: Thieme; 1973.; Gerbershagen HJ, Aduckathil S, van Wijck AJ, Peelen LM, Kalkman CJ, Meissner W. Pain intensity on the first day after surgery: a prospective cohort study comparing 179 surgical procedures. Anesthesiology. 2013;118(4):934-44. DOI:10.1097/ALN.0b013e31828866b3; Овечкин А.М., Баялиева А.Ж., Ежевская А.А., Еременко А.А., Заболотский Д.В., Заболотских И., Карелов А.Е., Корячкин В.А., Спасова А.П., Хороненко В.Э., Уваров Д.Н., Ульрих Г.Э., Шадрин Р.В. Послеоперационное обезболивание. Клинические рекомендации. Вестник интенсивной терапии имени А.И. Салтанова. 2019;(4):9-33. DOI:10.21320/1818-474X-2019-4-9-33; Gautam SKS, Das PK, Agarwal A, Kumar S, Dhiraaj S, Keshari A, Patro A. Comparative Evaluation of Continuous Thoracic Paravertebral Block and Thoracic Epidural Analgesia Techniques for Post-operative Pain Relief in Patients Undergoing Open Nephrectomy: A Prospective, Randomized, Single-blind Study. Anesth Essays Res. 2017;11(2):359-364. DOI:10.4103/0259-1162.194559; Forero M, Adhikary SD, Lopez H, Tsui C, Chin KJ. The Erector Spinae Plane Block: A Novel Analgesic Technique in Thoracic Neuropathic Pain. Reg Anesth Pain Med. 2016;41(5):621-627. DOI:10.1097/AAP.0000000000000451; Taketa Y, Irisawa Y, Fujitani T. Ultrasound-guided erector spinae plane block elicits sensory loss around the lateral, but not the parasternal, portion of the thorax. J Clin Anesth. 2018;47:84-85. DOI:10.1016/j.jclinane.2018.03.023; Taketa Y, Irisawa Y, Fujitani T. Comparison of ultrasoundguided erector spinae plane block and thoracic paravertebral block for postoperative analgesia after video-assisted thoracic surgery: a randomized controlled non-inferiority clinical trial. Reg Anesth Pain Med. 2019:rapm-2019-100827. DOI:10.1136/rapm-2019-100827. Epub ahead of print; Nagaraja PS, Ragavendran S, Singh NG, Asai O, Bhavya G, Manjunath N, Rajesh K. Comparison of continuous thoracic epidural analgesia with bilateral erector spinae plane block for perioperative pain management in cardiac surgery. Ann Card Anaesth. 2018;21(3):323-327. DOI:10.4103/aca.ACA_16_18; Celik M, Tulgar S, Ahiskalioglu A, Alper F. Is high volume lumbar erector spinae plane block an alternative to transforaminal epidural injection? Evaluation with MRI. Reg Anesth Pain Med. 2019:rapm-2019-100514. DOI:10.1136/rapm-2019-100514; Tulgar S, Kose HC, Selvi O, Senturk O, Thomas DT, Ermis MN, Ozer Z. Comparison of Ultrasound-Guided Lumbar Erector Spinae Plane Block and Transmuscular Quadratus Lumborum Block for Postoperative Analgesia in Hip and Proximal Femur Surgery: A Prospective Randomized Feasibility Study. Anesth Essays Res. 2018;12(4):825-831. DOI:10.4103/aer.AER_142_18; Aksu C, Şen MC, Akay MA, Baydemir C, Gürkan Y. Erector Spinae Plane Block vs Quadratus Lumborum Block for pediatric lower abdominal surgery: A double blinded, prospective, and randomized trial. J Clin Anesth. 2019;57:24-28. DOI:10.1016/j.jclinane.2019.03.006; Canturk M. Lumbar erector spinae plane block for postoperative analgesia after nephrectomy followed by emergent complication surgery. Minerva Anestesiol. 2019;85(9):1032-1033. DOI:10.23736/S0375-9393.19.13663-2; Elsharkawy H, El-Boghdadly K, Barrington M. Quadratus Lumborum Block: Anatomical Concepts, Mechanisms, and Techniques. Anesthesiology. 2019;130(2):322-335. DOI:10.1097/ALN.0000000000002524; Şahin A, Baran O. Effect of ultrasound-guided erector spinae plane block on post-surgical pain in patients undergoing nephrectomy: a single-center, randomized, double-blind, controlled trial. J Int Med Res. 2022;50(3):3000605221086737. DOI:10.1177/03000605221086737; Aksu C, Gürkan Y. Ultrasound guided erector spinae block for postoperative analgesia in pediatric nephrectomy surgeries. J Clin Anesth. 2018;45:35-36. DOI:10.1016/j.jclinane.2017.12.021; Onay M, Erdoğan Kayhan G, Özen A, Şanal Baş S, Yelken B. Comparison of ultrasound-guided quadratus lumborum block and erector spinae plane block in terms of their effects on postoperative pain in open nephrectomy. Minerva Anestesiol. 2023;89(1-2):32-39. DOI:10.23736/S0375-9393.22.16635-6; Sullivan TR, Kanda P, Gagne S, Costache I. Harlequin Syndrome Associated with Erector Spinae Plane Block. Anesthesiology. 2019;131(3):665. DOI:10.1097/ALN.0000000000002733; Elkoundi A, Eloukkal Z, Bensghir M, Belyamani L. Priapism following erector spinae plane block for the treatment of a complex regional pain syndrome. Am J Emerg Med. 2019;37(4):796.e3-796.e4. DOI:10.1016/j.ajem.2019.01.012; Selvi O, Tulgar S. Ultrasound guided erector spinae plane block as a cause of unintended motor block. Rev Esp Anestesiol Reanim (Engl Ed). 2018;65(10):589-592. (In English, Spanish). DOI:10.1016/j.redar.2018.05.009; Tulgar S, Selvi O, Senturk O, Serifsoy TE, Thomas DT. Ultrasound-guided Erector Spinae Plane Block: Indications, Complications, and Effects on Acute and Chronic Pain Based on a Single-center Experience. Cureus. 2019;11(1):e3815. DOI:10.7759/cureus.3815; Maddineni U, Maarouf R, Johnson C, Fernandez L, Kazior MR. Safe and Effective Use of Bilateral Erector Spinae Block in Patient Suffering from Post-Operative Coagulopathy Following Hepatectomy. Am J Case Rep. 2020;21:e921123. DOI:10.12659/AJCR.921123; Galacho J, Veiga M, Ormonde L. Erector spinae plane block and altered hemostasis: is it a safe option? -a case series. Korean J Anesthesiol. 2020;73(5):445-449. DOI:10.4097/kja.20078; https://www.urovest.ru/jour/article/view/828
-
5Academic Journal
Authors: N. I. Sorokin, V. E. Sinitsyn, O. A. Kharlova, A. A. Strigunov, O. Yu. Nesterova, R. A. Nikoghosyan, E. A. Galliamov, A. A. Kamalov, Н. И. Сорокин, В. Е. Синицын, О. А. Харлова, А. А. Стригунов, О. Ю. Нестерова, Р. А. Никогосян, Э. А. Галлямов, А. А. Камалов
Source: Urology Herald; Том 12, № 2 (2024); 108-119 ; Вестник урологии; Том 12, № 2 (2024); 108-119 ; 2308-6424 ; 10.21886/2308-6424-2024-12-2
Subject Terms: радикальная нефрэктомия, collecting duct (Bellini duct) renal cell carcinoma, partial nephrectomy, radical nephrectomy, рак протоков Bellini, резекция почки
File Description: application/pdf
Relation: https://www.urovest.ru/jour/article/view/859/554; Андреева Ю.Ю., Данилова Н.В., Москвина Л.В., Завалишина Л.Э., Кекеева Т.В., Мальков П.Г., Франк Г.А. Опухоли мочевыделительной системы и мужских половых органов. Морфологическая диагностика и генетика: Руководство для врачей. Москва: Практическая медицина; 2012.; Sui W, Matulay JT, Robins DJ, James MB, Onyeji IC, Roy-Choudhury A, Wenske S, DeCastro GJ. Collecting duct carcinoma of the kidney: Disease characteristics and treatment outcomes from the National Cancer Database. Urol Oncol. 2017;35(9):540.e13-540.e18. DOI:10.1016/j.urolonc.2017.04.010; Tang C, Zhou Y, Ge S, Yi X, Lv H, Zhou W. Incidence, Clinical Characteristics, and Survival of Collecting Duct Carcinoma of the Kidney: A Population-Based Study. Front Oncol. 2021;11:727222. DOI:10.3389/fonc.2021.727222; Cromie WJ, Davis CJ, DeTure FA. Atypical carcinoma of kidney: possibly originating from collecting duct epithelium. Urology. 1979;13(3):315-317. DOI:10.1016/0090-4295(79)90434-5; Fleming S, Lewi HJ. Collecting duct carcinoma of the kidney. Histopathology. 1986;10(11):1131-1141. DOI:10.1111/j.1365-2559.1986.tb02553.x; Karakiewicz PI, Trinh QD, Rioux-Leclercq N, de la Taille A, Novara G, Tostain J, Cindolo L, Ficarra V, Artibani W, Schips L, Zigeuner R, Mulders PF, Lechevallier E, Coulange C, Valeri A, Descotes JL, Rambeaud JJ, Abbou CC, Lang H, Jacqmin D, Mejean A, Patard JJ. Collecting duct renal cell carcinoma: a matched analysis of 41 cases. Eur Urol. 2007;52(4):1140-1145. DOI:10.1016/j.eururo.2007.01.070; Tokuda N, Naito S, Matsuzaki O, Nagashima Y, Ozono S, Igarashi T; Japanese Society of Renal Cancer. Collecting duct (Bellini duct) renal cell carcinoma: a nationwide survey in Japan. J Urol. 2006;176(1):40-43; discussion 43. DOI:10.1016/S0022-5347(06)00502-7; Cabanillas G, Montoya-Cerrillo D, Kryvenko ON, Pal SK, Arias-Stella JA 3rd. Collecting duct carcinoma of the kidney: diagnosis and implications for management. Urol Oncol. 2022;40(12):525-536. DOI:10.1016/j.urolonc.2021.04.041; Yin M, Wang W, Rosenberg J, Kaag M, Joshi M, Holder S, Tuanquin L, Drabick JJ. Targeted Therapy in Collecting Duct Carcinoma of the Kidney: A Case Report and Literature Review. Clin Genitourin Cancer. 2016;14(2):e203-e206. DOI:10.1016/j.clgc.2015.11.008; Ciszewski S, Jakimów A, Smolska-Ciszewska B. Collecting (Bellini) duct carcinoma: A clinical study of a rare tumour and review of the literature. Can Urol Assoc J. 2015;9(9-10):E589-E593. DOI:10.5489/cuaj.2932; Singh I, Nabi G. Bellini duct carcinoma: review of diagnosis and management. Int Urol Nephrol. 2002;34(1):91-95. DOI:10.1023/a:1021315130481; Zhou JX, He XR, Song GX, Zou ZG, Wang LH, Hu R, Li HX. [Clinicopathologic features with collecting duct carcinoma of kidney: report of 10 cases]. Zhonghua Bing Li Xue Za Zhi. 2018;47(2):123-127. (In Chinese) DOI:10.3760/cma.j.issn.0529-5807.2018.02.009; Chen J, Cai D, Gong K, Zhu S. Collecting Duct Carcinoma of the Kidney: Analysis of 74 Cases From Multiple Centers. Urology. 2022;164:163-168. DOI:10.1016/j.urology.2022.01.032; Pickhardt PJ, Siegel CL, McLarney JK. Collecting duct carcinoma of the kidney: are imaging findings suggestive of the diagnosis? AJR Am J Roentgenol. 2001;176(3):627-633. DOI:10.2214/ajr.176.3.1760627; Wang L, Peng L, Hou T, Shi Y. Renal collecting duct carcinoma: report of a case with unusual imaging findings regarding renal function. J Cancer Res Ther. 2013;9(2):331-333. DOI:10.4103/0973-1482.113425; Vanderbruggen W, Claessens M, De Coninck V, Duchateau A, Gevaert T, Joniau S, Hente R. Collecting duct renal cell carcinoma: a single centre series and review of the literature. Cent European J Urol. 2022;75(3):252-256. DOI:10.5173/ceju.2022.0143; Xie Z, Yadav S, Lohse CM, Cheville JC, Pagliaro LC, Shah PH, Boorjian SA, Thompson H, Leibovich BC, Costello BA. Collecting duct carcinoma: A single-institution retrospective study. Urol Oncol. 2022;40(1):13.e9-13.e18. DOI:10.1016/j.urolonc.2021.09.019; Pal SK, Choueiri TK, Wang K, Khaira D, Karam JA, Van Allen E, Palma NA, Stein MN, Johnson A, Squillace R, Elvin JA, Chmielecki J, Yelensky R, Yakirevich E, Lipson D, Lin DI, Miller VA, Stephens PJ, Ali SM, Ross JS. Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling. Eur Urol. 2016;70(3):516-521. DOI:10.1016/j.eururo.2015.06.019; Wang J, Papanicolau-Sengos A, Chintala S, Wei L, Liu B, Hu Q, Miles KM, Conroy JM, Glenn ST, Costantini M, Magi-Galluzzi C, Signoretti S, Choueiri T, Gallucci M, Sentinelli S, Fazio VM, Poeta ML, Liu S, Morrison C, Pili R. Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation. Oncotarget. 2016;7(21):29901-29915. DOI:10.18632/oncotarget.9093; Qian X, Wang Z, Zhang J, Wang Q, Zhou P, Wang S, Wang B, Qian C. Clinical Features and Prognostic Outcome of Renal Collecting Duct Carcinoma: 12 Cases from a Single Institution. Cancer Manag Res. 2020;12:3589-3595. DOI:10.2147/CMAR.S244094; Gollob JA, Upton MP, DeWolf WC, Atkins MB. Long-term remission in a patient with metastatic collecting duct carcinoma treated with taxol/carboplatin and surgery. Urology. 2001;58(6):1058. DOI:10.1016/s0090-4295(01)01411-x; Oudard S, Banu E, Vieillefond A, Fournier L, Priou F, Medioni J, Banu A, Duclos B, Rolland F, Escudier B, Arakelyan N, Culine S; GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales). Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales) study. J Urol. 2007;177(5):1698-1702. DOI:10.1016/j.juro.2007.01.063; Rizzo M, Chiellino S, Gernone A, Porta C. Cisplatin-based chemotherapy for the treatment of metastatic collecting duct carcinomas: A real-world, retrospective analysis. Front Oncol. 2022;12:939953. DOI:10.3389/fonc.2022.939953; Houmaidi AE, Aynaou M, Mhanna T, Dua Boating P, Chennoufi M, Barki A. A huge collecting duct carcinoma of the kidney in an elderly woman: Diagnosis and managment challenge (uncommon condition). Urol Case Rep. 2020;33:101375. DOI:10.1016/j.eucr.2020.101375; Chao D, Zisman A, Pantuck AJ, Gitlitz BJ, Freedland SJ, Said JW, Figlin RA, Belldegrun AS. Collecting duct renal cell carcinoma: clinical study of a rare tumor. J Urol. 2002;167(1):71-74. DOI:10.1016/s0022-5347(05)65385-2; Fuu T, Iijima K, Kusama Y, Otsuki T, Kato H. Complete response to combination therapy using nivolumab and ipilimumab for metastatic, sarcomatoid collecting duct carcinoma presenting with high expression of programmed death-ligand 1: a case report. J Med Case Rep. 2022;16(1):193. DOI:10.1186/s13256-022-03426-3; Xiao R, Liu C, He W, Ma L. Prognostic Factors and a Nomogram Predicting Overall Survival and Cancer-Specific Survival for Patients with Collecting Duct Renal Cell Carcinoma. Biomed Res Int. 2021;2021:6736008. DOI:10.1155/2021/6736008; https://www.urovest.ru/jour/article/view/859
-
6Academic Journal
Authors: D. V. Semenov, R. V. Orlova, V. I. Shirokorad, S. V. Kostritsky, M. I. Gluzman, Yu. S. Korneva, Д. В. Семенов, Р. В. Орлова, В. И. Широкорад, С. В. Кострицкий, М. И. Глузман, Ю. С. Корнева
Source: Siberian journal of oncology; Том 23, № 1 (2024); 53-62 ; Сибирский онкологический журнал; Том 23, № 1 (2024); 53-62 ; 2312-3168 ; 1814-4861
Subject Terms: метастазэктомия, cytoreductive nephrectomy, metastasectomy, циторедуктивная нефрэктомия
File Description: application/pdf
Relation: https://www.siboncoj.ru/jour/article/view/2964/1202; Capitanio U., Bensalah K., Bex A., Boorjian S.A., Bray F., Coleman J., Gore J.L., Sun M., Wood C., Russo P. Epidemiology of Renal Cell Carcinoma. Eur Urol. 2019; 75(1): 74–84. doi:10.1016/j.eururo.2018.08.036.; Ljungberg B., Albiges L., Abu-Ghanem Y., Bensalah K., Dabestani S., Fernández-Pello S., Giles R.H., Hofmann F., Hora M., Kuczyk M.A., Kuusk T., Lam T.B., Marconi L., Merseburger A.S., Powles T., Staehler M., Tahbaz R., Volpe A., Bex A. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update. Eur Urol. 2019; 75(5): 799–810. doi:10.1016/j.eururo.2019.02.011.; Culp S.H., Tannir N.M., Abel E.J., Margulis V., Tamboli P., Matin S.F., Wood C.G. Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy? Cancer. 2010; 116(14): 3378–88. doi:10.1002/cncr.25046.; Rini B.I., Dorff T.B., Elson P., Rodriguez C.S., Shepard D., Wood L., Humbert J., Pyle L., Wong Y.N., Finke J.H., Rayman P.A., Larkin J.M., Garcia J.A., Plimack E.R. Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial. Lancet Oncol. 2016; 17(9): 1317–24. doi:10.1016/S1470-2045(16)30196-6.; Méjean A., Ravaud A., Thezenas S., Colas S., Beauval J.B., Bensalah K., Geoffrois L., Thiery-Vuillemin A., Cormier L., Lang H., Guy L., Gravis G., Rolland F., Linassier C., Lechevallier E., Beisland C., Aitchison M., Oudard S., Patard J.J., Theodore C., Chevreau C., Laguerre B., Hubert J., Gross-Goupil M., Bernhard J.C., Albiges L., Timsit M.O., Lebret T., Escudier B. Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma. N Engl J Med. 2018; 379(5): 417–27. doi:10.1056/NEJMoa1803675.; Omid S., Abufaraj M., Remzi M. Metastasectomy in patients with renal cell carcinoma: when and how? Curr Opin Urol. 2020; 30(4): 602–9. doi:10.1097/MOU.0000000000000768.; Isali I., Braun A., Bukavina L., Psutka S.P. Role of cytoreductive surgery in the era of immunotherapy. Curr Opin Urol. 2022; 32(6): 618–26. doi:10.1097/MOU.0000000000001037.; Ciccarese C., Iacovelli R., Porta C., Procopio G., Bria E., Astore S., Cannella M.A., Tortora G. Efficacy of VEGFR-TKIs plus immune checkpoint inhibitors in metastatic renal cell carcinoma patients with favorable IMDC prognosis. Cancer Treat Rev. 2021; 100. doi:10.1016/j.ctrv.2021.102295.; Kim S.H., Suh Y.S., Lee D.E., Park B., Joo J., Joung J.Y., Seo H.K., Lee K.H., Chung J. A retrospective comparative study of progression-free survival and overall survival between metachronous and synchronous metastatic renal cell carcinoma in intermediate- or poor-risk patients treated with VEGF-targeted therapy. Oncotarget. 2017; 8(55): 93633–43. doi:10.18632/oncotarget.20674.; Courcier J., Dalban C., Laguerre B., Ladoire S., Barthélémy P., Oudard S., Joly F., Gravis G., Chevreau C., Geoffrois L., Deluche É., Rolland F., Topart D., Culine S., Négrier S., Mahammedi H., Tantot F., Jamet A., Escudier B., Flippot R., Albigès L. Primary Renal Tumour Response in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma: Results from the GETUG-AFU 26 NIVOREN Trial. Eur Urol. 2021; 80(3): 325–9. doi:10.1016/j.eururo.2021.05.020.; Kato R., Naito S., Numakura K., Hatakeyama S., Koguchi T., Kojima T., Kawasaki Y., Kandori S., Kawamura S., Arai Y., Ito A., Nishiyama H., Kojima Y., Ohyama C., Habuchi T., Tsuchiya N., Obara W. Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective study. Int J Clin Oncol. 2022; 27(3): 563–73. doi:10.1007/s10147-021-02091-8. Erratum in: Int J Clin Oncol. 2023; 28(5): 726–7.; Dr Hall B., Abel E.J. The Evolving Role of Metastasectomy for Patients with Metastatic Renal Cell Carcinoma. Urol Clin North Am. 2020; 47(3): 379–88. doi:10.1016/j.ucl.2020.04.012.; Wu K., Liu Z., Shao Y., Li X. Nomogram Predicting Survival to Assist Decision-Making of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma. Front Oncol. 2020; 10. doi:10.3389/fonc.2020.592243.; Verbiest A., Couchy G., Job S., Caruana L., Lerut E., Oyen R., de Reyniès A., Tosco L., Joniau S., Van Poppel H., Van Raemdonck D., Van Den Eynde K., Wozniak A., Zucman-Rossi J., Beuselinck B. Molecular Subtypes of Clear-cell Renal Cell Carcinoma are Prognostic for Outcome After Complete Metastasectomy. Eur Urol. 2018; 74(4): 474–80. doi:10.1016/j.eururo.2018.01.042.; https://www.siboncoj.ru/jour/article/view/2964
-
7Academic Journal
Authors: D. V. Semenov, R. V. Orlova, V. I. Shirokorad, S. V. Kostritskiy, N. A. Karlova, Д. В. Семенов, Р. В. Орлова, В. И. Широкорад, С. В. Кострицкий, Н. А. Карлова
Source: Cancer Urology; Том 20, № 3 (2024); 22-32 ; Онкоурология; Том 20, № 3 (2024); 22-32 ; 1996-1812 ; 1726-9776
Subject Terms: системная терапия, циторедуктивная нефрэктомия, метастазэктомия, общая выживаемость, прогностическая группа
File Description: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/1766/1571; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1766/1435; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1766/1436; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1766/1437; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1766/1438; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1766/1439; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1766/1440; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1766/1441; Capitanio U., Bensalah K., Bex A. et al. Epidemiology of renal cell carcinoma. Eur Urol 2019;75:74–84. DOI:10.1016/j.eururo.2018.08.036; Doppalapudi S.K., Leopold Z.R., Thaper A. et al. Clearing up clear cell: clarifying the immuno-oncology treatment landscape for metastatic clear cell RCC. Cancers (Basel) 2021;13(16):4140. DOI:10.3390/cancers13164140; Choi C.I., Kang M., Sung H.H. et al. Oncologic outcomes of cytoreductive nephrectomy in synchronous metastatic renal-cell carcinoma: a single-center experience. Clin Genitourin Cancer 2018;16(6):e1189–99. DOI:10.1016/j.clgc.2018.07.030; Omid S., Abufaraj M., Remzi M. Metastasectomy in patients with renal cell carcinoma: when and how? Curr Opin Urol 2020;30(4):602–9. DOI:10.1097/mou.0000000000000768; Prunty M., Bukavina L., Psutka S.P. Metastasectomy in kidney cancer: current indications and treatment approaches. Curr Opin Support Palliat Care 2021;15(4):266–75. DOI:10.1097/spc.0000000000000574; Zhao Y., Li J., Li C. et al. Prognostic factors for overall survival after lung metastasectomy in renal cell cancer patients: a systematic review and meta- analysis. Int J Surg 2017;41:70–7. DOI:10.1016/j.ijsu.2017.03.062; Ouzaid I., Capitanio U., Staehler M. et al. Surgical metastasectomy in renal cell carcinoma: a systematic review. Eur Urol Oncol 2019;2:141–9. DOI:10.1016/j.euo.2018.08.028; Russo P., Synder M., Vickers A. et al. Cytoreductive nephrectomy and nephrectomy/complete metastasectomy for metastatic renal cancer. Sci World J 2007;7:982931. DOI:10.1100/tswurol.2007.60; Dr Hall B., Abel E.J. The evolving role of metastasectomy for patients with metastatic renal cell carcinoma. Urol Clin North Am 2020;47(3):379–88. DOI:10.1016/j.ucl.2020.04.012; Sun M., Meyer C.P., Karam J.A. et al. Predictors, utilization patterns, and overall survival of patients undergoing metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy. Eur J Surg Oncol 2018;44(9):1439–45. DOI:10.1016/j.ejso.2018.05.026; Dragomir A., Nazha S., Wood L.A. et al. Outcomes of complete metastasectomy in metastatic renal cell carcinoma patients: the Canadian Kidney Cancer information system experience. Urol Oncol 2020;38(10):799.e1–10. DOI:10.1016/j.urolonc.2020.07.021; Fares A.F., Araujo D.V., Calsavara V. et al. Complete metastasectomy in renal cell carcinoma: a propensity-score matched by the International Metastatic RCC Database Consortium prognostic model. Ecancermedicalscience 2019;13:967. DOI:10.3332/ecancer.2019.967; Wu K., Liu Z., Shao Y., Li X. Nomogram predicting survival to assist decision-making of metastasectomy in patients with metastatic renal cell carcinoma. Front Oncol 2020;10:592243. DOI:10.3389/fonc.2020.592243; Staehler M., Haseke N., Zilinberg E. et al. Complete remission achieved with angiogenic therapy in metastatic renal cell carcinoma including surgical intervention. Urol Oncol 2010;28(2):139–44. DOI:10.1016/j.urolonc.2009.03.033; Ishihara H., Takagi T., Kondo T. et al. Prognostic impact of metastasectomy in renal cell carcinoma in the postcytokine therapy era. Urol Oncol 2021;39(1):77.e17–25. DOI:10.1016/j.urolonc.2020.08.011; Kim S.H., Park W.S., Park B. et al. A retrospective analysis of the impact of metastasectomy on prognostic survival according to metastatic organs in patients with metastatic renal cell carcinoma. Front Oncol 2019;9:413. DOI:10.3389/fonc.2019.00413; Kato S., Demura S., Murakami H. et al. Clinical outcomes and prognostic factors following the surgical resection of renal cell carcinoma spinal metastases. Cancer Sci 2021;112(6):2416–25. DOI:10.1111/cas.14902; Langerhuizen D.W., Janssen S.J., van der Vliet Q.M. et al. Metastasectomy, intralesional resection, or stabilization only in the treatment of bone metastases from renal cell carcinoma. J Surg Oncol 2016;114(2):237–45. DOI:10.1002/jso.2428; https://oncourology.abvpress.ru/oncur/article/view/1766
-
8Academic Journal
Authors: N. K. Zhumabaev, M. I. Komarov, A. V. Klimov, V. B. Matveev, I. S. Stilidi, Н. К. Жумабаев, М. И. Комаров, А. В. Климов, В. Б. Матвеев, И. С. Стилиди
Source: Cancer Urology; Том 19, № 4 (2023); 15-23 ; Онкоурология; Том 19, № 4 (2023); 15-23 ; 1996-1812 ; 1726-9776
Subject Terms: парциальная нефрэктомия, recurrence, repeat kidney resection, partial nephrectomy, рецидив, повторная резекция почки
File Description: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/1719/1491; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1719/1383; Ljungberg B., Albiges L., Bensalah K. et al. EAU guidelines on renal cell carcinoma: 2020 update. Eur Urol 2020;67:913e24.; Mir M.C., Derweesh I., Porpiglia F. et al. Partial nephrectomy versus radical nephrectomy for clinical T1b and T2 renal tumors: a systematic review and meta-analysis of comparative studies. Eur Urol 2017;71(4):606–17. DOI:10.1016/j.eururo.2016.08.060; Henderickx M.M., Baldew S.V., Marconi L. et al. Surgical margins after partial nephrectomy as prognostic factor for the risk of local recurrence in pT1 RCC: a systematic review and narrative synthesis. World J Urol 2022;40(9):2169–79. DOI:10.1007/s00345-022-04016-0; Veccia A., Falagario U., Martini A. et al. Upstaging to pT3a in patients undergoing partial or radical nephrectomy for cT1 renal tumors: a systematic review and meta-analysis of outcomes and predictive factors. Eur Urol Focus 2021;7(3):574–81. DOI:10.1016/j.euf.2020.05.013; Margulis V., McDonald M., Tamboli P. et al. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma. J Urol 2009;181(5):2044–51. DOI:10.1016/j.juro.2009.01.043; Weight C.J., Larson B.T., Fergany A.F. et al. Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cTlb renal masses. J Urol 2010;183(4):1317–23. DOI:10.1016/j.juro.2009.12.030; Kriegmair M.C., Bertolo R., Karakiewicz P.I. et al. Systematic review of the management of local kidney cancer relapse. Eur Urol Oncol 2018;1(6):512–23. DOI:10.1016/j.euo.2018.06.007; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013;3:1–150.; Levey A.S., Stevens L.A. Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis 2010;55(4):622–7. DOI:10.1053/j.ajkd.2010.02.337; Dindo D., Demartines N., Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240(2):205–13. DOI:10.1097/01.sla.0000133083.54934.ae; Liu N.W., Khurana K., Sudarshan S. et al. Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes. J Urol 2010;183(5):1719–24. DOI:10.1016/j.juro.2010.01.010; Shah P., Patel V.R., Kozel Z. et al. Laparoscopic completion nephrectomy for local surgical bed recurrence after partial nephrectomy: an analysis of procedural complexity and feasibility. J Endourol 2018;32(12):1114–9. DOI:10.1089/end.2018.0384; Autorino R., Khalifeh A., Laydner H. et al. Repeat robot-assisted partial nephrectomy (RAPN): feasibility and early outcomes. BJU Int 2013;111(5):767–72. DOI:10.1111/j.1464-410X.2013.11800.x; Morgan M.A., Roberts N.R., Pino L.A. et al. Percutaneous cryoablation for recurrent low grade renal cell carcinoma after failed nephron-sparing surgery. Can J Urol 2013;20(2):6933–7.; Johnson A., Sudarshan S., Liu J. et al. Feasibility and outcomes of repeat partial nephrectomy. J Urol 2008;180(1):89–93. DOI:10.1016/j.juro.2008.03.030; Gurram S., Friedberg N.A., Gordhan C. et al. Reoperative partial nephrectomy-does previous surgical footprint impact outcomes? J Urol 2021;206(3):539–47. DOI:10.1097/JU.0000000000001837; Yoshida K., Kondo T., Takagi T. et al. Clinical outcomes of repeat partial nephrectomy compared to initial partial nephrectomy of a solitary kidney. Int J Clin Oncol 2020;25(6):1155–62. DOI:10.1007/s10147-020-01633-w; Okhawere K.E., Grauer R., Zuluaga L. et al. Operative and oncological outcomes of salvage robotic radical and partial nephrectomy: a multicenter experience. J Robotic Surg 2023;17(4):1579–85. DOI:10.1007/s11701-023-01538-6; Гулиев Б.Г. Робот-ассистированная повторная резекция рецидивных опухолей почки. Онкоурология 2023;19(1):37–45. DOI:10.17650/1726-9776-2023-19-1-37-45; https://oncourology.abvpress.ru/oncur/article/view/1719
-
9Academic Journal
Authors: М. И. Волкова, Д. А. Носов, Б. Я. Алексеев, О. А. Гладков, В. Б. Матвеев
Source: Malignant tumours; Том 14, № 3s2-2 (2024); 207-220 ; Злокачественные опухоли; Том 14, № 3s2-2 (2024); 207-220 ; 2587-6813 ; 2224-5057
Subject Terms: циторедуктивная нефрэктомия, иммунотерапия, ингибиторы m-TOR, тирозинкиназные ингибиторы
File Description: application/pdf
Relation: https://www.malignanttumors.org/jour/article/view/1389/994; https://www.malignanttumors.org/jour/article/view/1389
-
10Academic Journal
Authors: Zh. Е. Sabelnikova, М. М. Sarycheva, Е. Ya. Mozerova, А. V. Vazhenin, А. А. Lozhkov, Ж. Е. Сабельникова, М. М. Сарычева, Е. Я. Мозерова, А. В. Важенин, А. А. Ложков
Contributors: The article was prepared without sponsorship, Статья подготовлена без спонсорской поддержки
Source: Malignant tumours; Том 14, № 2 (2024); 44-50 ; Злокачественные опухоли; Том 14, № 2 (2024); 44-50 ; 2587-6813 ; 2224-5057
Subject Terms: почечная токсичность, kidney resection, nephrectomy, stereotactic radiation therapy, renal toxicity, резекция почки, нефрэктомия, стереотаксическая лучевая терапия
File Description: application/pdf
Relation: https://www.malignanttumors.org/jour/article/view/1312/943; Злокачественные новообразования в России в 2021 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022. 252 с.; Клинические рекомендации. Злокачественные новообразования паренхимы почки, 2021. Доступно по: https://cr.minzdrav.gov.ru/recomend/10_2; Gill I.S., Kavoussi L.R., Lane B.R., et al. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 2007;178(1):41–6. doi:10.1016/j.juro.2007.03.038; Magee D.E., Wong J.K., Correa A.F. Stereotactic ablative body radiotherapy: an emerging weapon in the treatment armamentarium for renal cell carcinoma or a potential avenue for overtreatment? Eur Urol 2022;82(6):623–624. doi:10.1016/j.eururo.2022.07.020; Mir M.C., Derweesh I., Porpiglia F., et al. Partial nephrectomy versus radical nephrectomy for clinical T1b and T2 renal tumors : a systematic review and meta‑analysis of comparative studies. Eur Urol 2017;71(4):606−17. doi:10.1016/j.eururo.2016.08.060; Forbes C.M., Rendon R.A., Finelli A., et al. Disease progression and kidney function after partial vs. radical nephrectomy for T1 renal cancer. Urol Oncol 2016;34(11):486.e17−23. doi:10.1016/j.urolonc.2016.05.034.; Jiang Y.L., Peng C.X., Wang H.Z., Qian L.J. Comparison of the long‑term follow‑up and perioperative outcomes of partial nephrectomy and radical nephrectomy for 4 cm to 7 cm renal cell carcinoma : a systematic review and meta‑analysis. BMC Urol 2019;19(1):48. doi:10.1186/s12894-019-0480-6; Rühle A., Andratschke N., Siva S., Guckenberger M. Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma? Clin Transl Radiat Oncol 2019;18:104–112. doi:10.1016/j.ctro.2019.04.012; Haque W., Verma V., Lewis G.D., et al. Utilization of radiotherapy and stereotactic body radiation therapy for renal cell cancer in the USA. Future Oncol 2018;14(9):819–827. doi:10.2217/fon-2017-0536.; Ali M., Mooi J., Lawrentschuk N., et al. The role of stereotactic ablative body radiotherapy in renal cell carcinoma. Eur Urol 2022;82(6):613–622. doi:10.1016/j.eururo.2022.06.017; Siva S., Ali M., Correa R.J.M., et al. 5‑year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta‑analysis from IROCK (the International Radiosurgery Consortium of the Kidney). Lancet Oncol 2022;23(12):1508–1516. doi:10.1016/S1470-2045(22)00656-8; Siva S., Pham D., Kron T., et al. Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial. BJU Int 2017;120(5):623–630. doi:10.1111/bju.13811; Siva S., Ellis R.J., Ponsky L., et al. Consensus statement from the International radiosurgery oncology consortium for kidney for primary renal cell carcinoma. Future Oncol 2016;12(5):637–45. doi:10.2217/fon.16.2; Grant S.R., Lei X., Hess K.R., et al. Stereotactic body radiation terapy for the definitive treatment of early stage kidney cancer: a survival comparison with surgery, tumor ablation, and observation. Adv Radiat Oncol 2020;5(3):495–502. doi:10.1016/j.adro.2020.01.002.; https://www.malignanttumors.org/jour/article/view/1312
-
11Academic Journal
Authors: Z. A. Kadyrov, A. Yu. Odilov, M. V. Faniev, N. V. Demin, З. А. Кадыров, А. Ю. Одилов, М. В. Фаниев, Н. В. Демин
Source: Andrology and Genital Surgery; Том 25, № 1 (2024); 123-132 ; Андрология и генитальная хирургия; Том 25, № 1 (2024); 123-132 ; 2412-8902 ; 2070-9781
Subject Terms: почка, laparoscopicy, nephrectomy, retroperitoneoscopicy, the Clavien-Dindo classification, kidney, лапароскопия, нефрэктомия, ретроперитонеоскопия, классификация Клавьена – Диндо
File Description: application/pdf
Relation: https://agx.abvpress.ru/jour/article/view/743/574; Кадыров З.А. Лапароскопические и ретроперитонеоскопические операции в урологии. M.: ГЕОТАР-Медиа, 2017. 488 с.; Angus Chin On Luk, Pandian Rajadoss Muthu, Heer Rakesh. Laparoscopic renal surgery is here to stay. Arab Journal of Urology 2018;16(3):314–320.; El-tohamy S.A., Shello H.M. Retroperitoneal versus transperitoneal laparoscopy for simple nephrectomy. Egypt J Anaesth 2013;29:109–116.; Pierorazio P.M., Hyams E.S., Lin B.M. et al. Laparoscopic radical nephrectomy for large renal masses: critical assessment of perioperative and oncologic outcomes of stage T2a and T2b tumors. Urology 2012;79(3):570–575. DOI:10.1016/j.urology.2011.10.065. PMID: 22386399.; Selçuk E., Öner Ş ., Tzevat T., Tayfun O. et al. Retroperitoneoscopic nephrectomy has better perioperative outcomes than transperitoneal laparoscopic nephrectomy in obese patients. Turkish J Urol 2012;38(2):80–87. DOI:10.5152/tud.2012.019.; De Cassai A., Boscolo A., Tonetti T. et al. Assignment of ASA-physical status relates to anesthesiologists’ experience: a survey-based national-study Korean Journal of Anesthesiology 2019;72(1):53–59. DOI:10.4097/kja.d.18.00224.; Dindo D., Demartines N., Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213.; Mitropoulos D., Artibani W., Biyani C.S. et al. Validation of the Clavien-Dindo grading system in urology by the European Association of urology guidelines ad hoc panel. European Urology Focus 2018;4(4):608–613. DOI:10.1016/j.euf.2017.02.014.; Ritchey M.L., Kelalis P.P., Breslow N. et al. Surgical complications after nephrectomy for Wilms’ tumor. Surg Gynecol Obstet. 1992;175(6):507–514.; Fahlenkamp D., Rassweiler J., Fornara P. et al. Complications of laparoscopic procedures in urology: experience with 2,407 procedures at 4 German centers. Journal of Urology 1999;162(3 Pt 1):765–771. DOI:10.1097/00005392-199909010-00038.; Ölçücüoğlu E. Comparing the complications of laparoscopically performed simple, radical and donor nephrectomy. Turk J Med Sci 2020;50:922–929. DOI:10.3906/sag-1910-120.; Widmer J.D., Schlegel A., Kron P. et al. Hand-assisted livingdonor nephrectomy: a retrospective comparison of two techniques. BMC Urol 2018;18(1):39. DOI:10.1186/s12894-018-0355-2.; Кадыров З.А., Одилов А.Ю. Осложнения традиционной, лапароскопической и ретроперитонеоскопической нефрэктомии при различных заболеваниях почек. Урология 2020;4:151–156. DOI:10.18565/urology.2020.4.151–156.; Кадыров З.А., Одилов А.Ю., Ягудаев Д.М. Сравнительный анализ интра- и послеоперационных осложнений ретроперитонеоскопической и лапароскопической нефрэктомии при опухолях больших размеров. Онкоурология 2018;14(4):22–28. DOI: https://doi.org/10.17650/1726-9776-2018-14-4-22-28.; Pareek G., Hedican S.P., Gee J.R. et al. Meta-analysis of the Complications of Laparoscopic Renal Surgery: Comparison of Procedures and Techniques. J Urol 2006;175(4):1208–1213. DOI:10.1016/S0022-5347(05)00639-7. PMID: 16515961.; Elsamra S., Pareek G. Complications of Laparoscopic Renal Surgery. Int J Urol 2010;17(3):206–214. DOI:10.1111/j.1442- 2042.2010.02446.x. PMID: 20409216 Review.; Klap J., Butow Z., Champy C.M. et al. 1,000 Retroperitoneoscopic Procedures of the Upper Urinary Tract: Analysis of Complication. Urol Int 2019;102(4):406–412. DOI:10.1159/000497038. Epub 2019 Mar 6 PMID: 30840956.; Люлько А.В., Мягкий В.М. Ошибки и осложнений нефрэктомии. Клиническая хирургия 1979;12:36–37.; Ritchey M.L., Shamberger R.C., Haase G. et al. Surgical complications after primary nephrectomy for Wilms’ tumor: report from the National Wilms’ Tumor Study Group. J Am Coll Surg 2001;192(1):63–68. DOI:10.1016/s1072-7515(00)00749-3.; Simon S.D., Castle E.P., Ferrigni R.G. et al. Complications of laparoscopic nephrectomy: the Mayo clinic experience. J Urol 2004;171:1447–1450. DOI:10.1097/01.ju.0000117942.61971.41.; Lombardo R., Martos R., Ribal M.J. et al. Retroperitoneoscopy in urology: a systematic review. Minerva Urol Nefrol 2019;71(1):9–16.; Montes S.F.-P., Rodríguez I.G., Ugarteburu R.G. et al. Intraoperative laparoscopic complications for urological cancer procedures. World J Clin Cases 2015;3(5):450–456.; Creta M., Calogero A., Sagnelli C. et al. Donor and Recipient Outcomes following Robotic-Assisted Laparoscopic Living Donor Nephrectomy: A Systematic Review. Biomed Res Int 2019;2019:1729138. DOI:10.1155/2019/1729138.; Khan A., Palit V., Myatt A. et al. Assessment of Clavien-Dindo classification in patients > 75 years undergoing nephrectomy/ nephroureterectomy. Urol Ann 2013;5(1):18–22.; Xu H., Ding Q., Jiang H.W. Fewer complications after laparoscopic nephrectomy as compared to the open procedure with the modified Clavien classification system-a retrospective analysis from southern China. World J Surg Oncol 2014;12:242. DOI:10.1186/1477-7819-12-242.; Srivastava A., Bansal A., Sureka S.K. et al. A retrospective analysis of complications of laparoscopic left donor nephrectomy using the Kocak’s modification of Clavien-Dindo system. Indian Journal of Urology 2018;34(2):133–139.; Permpongkosol S., Link R.E., Su L.M. et al. Complications of 2,775 urological laparoscopic procedures: 1993 to 2005. Journal of Urology 2007;177(2):580–585. DOI:10.1016/j.juro.2006.09.031.; Kim B.S., Yoo E.S., Kwon T.G. Complications of transperitoneal laparoscopic nephrectomy: a single-center experience. Urology 2009;73(6):1283–1287. DOI:10.1016/j.urology.2009.01.017.; Hsiao W., Pattaras J.G. Not so «simple» laparoscopic nephrectomy: outcomes and complications of a 7-year experience. Journal of Endourology 2008;22(10):2285–2290. DOI:10.1089/end.2008.9718.; Garg M., Singh V., Sinha R.J., Sharma P. Prospective randomized comparison of transperitoneal vs retroperitoneal laparoscopic simple nephrectomy. Urology 2014;84(2):335–339. DOI:10.1016/j.urology.2014.04.038.; Parsons J.K., Varkarakis I., Rha K.H. et al. Complications of abdominal urologic laparoscopy: longitudinal five-year analysis. Urology 2004;63:27–32. DOI:10.1016/j.urology.2003.10.003.; Campos-Sañudo J.A., Ballestero-Diego R., Zubillaga-Guerrero S. et al. Complications and mortality after radical nephrectomy in a low-volume hospital. Arch Esp Urol 2019;72(7):653–661; Arfi N., Baldini A., Decaussin-Petrucci M. et al. Impact of obesity on complications of laparoscopic simple or radical nephrectomy. Current Urology 2015;8(3):149–155. DOI:10.1159/000365707.; Birkmeyer J.D., Finks J.F., O’Reilly A. et al. Surgical skill and complication rates after bariatric surgery. New England Journal of Medicine 2013;369(15):1434–1442. DOI:10.1056/NEJMsa1300625.; Hsu R.C.J., Salika T., Maw J. et al. Influence of hospital volume on nephrectomy mortality and complications: a systematic review and meta-analysis stratified by surgical type. BMJ Open 2017;7(9):e016833. DOI:10.1136/bmjopen-2017-016833.; Pieper D., Mathes T., Neugebauer E., Eikermann M. State of evidence on the relationship between high-volume hospitals and outcomes in surgery: a systematic review of systematic reviews. Journal of the American College of Surgeons 2013;216(5):1015– 1025. doi:10.1016/j.jamcollsurg.2012.12.049.; Xu B., Hu J., Chen A. et al. Risk Factors Related with Retroperitoneal Laparoscopic Converted to Open Nephrectomy for Nonfunctioning Renal Tuberculosis. J Endourol 2017;31(6):588–592.; Shah P., Ganpule A., Mishra S. et al. Prospective study of preoperative factors predicting intraoperative difficulty during laparoscopic transperitoneal simple nephrectomy. Urol Ann 2015;7(4):448–453.; Gahlawat S., Sood R., Sharma U. et al. Can preoperative clinicоradiological parameters predict the difficulty during laparoscopic retroperitoneal simple nephrectomy? A prospective study. Urol Ann 2018;10(2):191–197.; https://agx.abvpress.ru/jour/article/view/743
-
12Academic Journal
Authors: Gennady I. Lobov, Galina T. Ivanova
Source: Интегративная физиология, Vol 2, Iss 1 (2021)
Subject Terms: 0301 basic medicine, 03 medical and health sciences, 0302 clinical medicine, хроническая болезнь почек, Physiology, дилатация, QP1-981, нефрэктомия, церебральные артерии, ацетилхолин, NO
Access URL: https://intphysiology.ru/index.php/main/article/download/79/72
https://doaj.org/article/c787313b18464a7895c06791ff29220b
https://intphysiology.ru/index.php/main/article/download/79/72
https://cyberleninka.ru/article/n/rol-k-kanalov-i-serovodoroda-v-regulyatsii-tonusa-tserebralnyh-arteriy-nefrektomirovannyh-krys/pdf
https://intphysiology.ru/index.php/main/article/view/79
https://cyberleninka.ru/article/n/rol-k-kanalov-i-serovodoroda-v-regulyatsii-tonusa-tserebralnyh-arteriy-nefrektomirovannyh-krys -
13
Subject Terms: TGF-β, collagen, FLI1, коллаген, CKD, nephrectomy, ХПН, нефрэктомия, vascular fibrosis, сосудистый фиброз
-
14Academic Journal
Authors: V. K. Dzitiev, N. I. Sorokin, V. E. Sinitsyn, O. Yu. Nesterova, N. V. Danilova, E. M. Badmaeva, A. A. Strigunov, D. D. Tsurskaya, A. A. Kamalov, В. К. Дзитиев, Н. И. Сорокин, В. Е. Синицын, О. Ю. Нестерова, Н. В. Данилова, Е. М. Бадмаева, А. А. Стригунов, Д. Д. Цурская, А. А. Камалов
Contributors: The study was not sponsored, Исследование не имело спонсорской поддержки
Source: Urology Herald; Том 11, № 2 (2023); 171-180 ; Вестник урологии; Том 11, № 2 (2023); 171-180 ; 2308-6424 ; 10.21886/2308-6424-2023-11-2
Subject Terms: нефрэктомия, renal pelvis, staghorn stone, urolithiasis, nephrectomy, коралловидный нефролитиаз, мочекаменная болезнь
File Description: application/pdf
Relation: https://www.urovest.ru/jour/article/view/732/478; Kalayci OT, Bozdag Z, Sonmezgoz F, Sahin N. Squamous cell carcinoma of the renal pelvis associated with kidney stones: radiologic imaging features with gross and histopathological correlation. J Clin Imaging Sci. 2013;3:14. DOI:10.4103/2156-7514.109741; Mizusawa H, Komiyama I, Ueno Y, Maejima T, Kato H. Squamous cell carcinoma in the renal pelvis of a horseshoe kidney. Int J Urol. 2004;11(9):782-4. DOI:10.1111/j.1442-2042.2004.00873.x; Jongyotha K, Sriphrapradang C. Squamous Cell Carcinoma of the Renal Pelvis as a Result of Long-Standing Staghorn Calculi. Case Rep Oncol. 2015;8(3):399-404. DOI:10.1159/000440764; Paonessa J, Beck H, Cook S. Squamous cell carcinoma of the renal pelvis associated with kidney stones: a case report. Med Oncol. 2011 Dec;28(Suppl 1):S392-4. DOI:10.1007/s12032-010-9704-z; Holmäng S, Lele SM, Johansson SL. Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome. J Urol. 2007 Jul;178(1):51-6. DOI:10.1016/j.juro.2007.03.033; Xiao J, Lei J, He L, Yin G. Renal calculus complicated with squamous cell carcinoma of renal pelvis: Report of two cases. Can Urol Assoc J. 2015 May-Jun;9(5-6):E310-2. DOI:10.5489/cuaj.2441; Nair B, Sukumar S, Poolari GK, Appu T. Azathioprine-induced squamous cell carcinoma of the kidney. Scand J Urol Nephrol. 2007;41(2):173-5. DOI:10.1080/00365590601017394; O'Daly BJ, O'Brien MF, Dowling CM, Crotty TB, Watson AJ, Moriarty MJ, Mulvin DW. Squamous cell carcinoma of the renal pelvis after curative retroperitoneal radiotherapy for seminoma. Urology. 2007 Oct;70(4):812.e3-6. DOI:10.1016/j.urology.2007.07.043; Schena S, Bogetti D, Setty S, Kadkol S, Bruno A, Testa G, Panaro F, Benedetti E, Sankary H. Squamous cell carcinoma in a chronically rejected renal allograft. Am J Transplant. 2004 Jul;4(7):1208-11. DOI:10.1111/j.1600-6143.2004.00481.x; Kayaselçuk F, Bal N, Guvel S, Egilmez T, Kilinc F, Tuncer I. Carcinosarcoma and squamous cell carcinoma of the renal pelvis associated with nephrolithiasis: a case report of each tumor type. Pathol Res Pract. 2003;199(7):489-92. DOI:10.1078/0344-0338-00451; Cadeddu JA, Jarrett TW. Hypercalcemia associated with squamous cell carcinoma of the renal pelvis. J Urol. 1998 Nov;160(5):1798. PMID: 9783957; Sandhu DP, Cooksey G, O'Reilly K, Gordon-Smart J. Squamous cell carcinoma of the renal pelvis associated with urinary diversion and humoral hypercalcaemic malignancy syndrome. J R Coll Surg Edinb. 1991 Jun;36(3):192-4. PMID: 1824553; Berz D, Rizack T, Weitzen S, Mega A, Renzulli J, Colvin G. Survival of patients with squamous cell malignancies of the upper urinary tract. Clin Med Insights Oncol. 2012;6:11-8. DOI:10.4137/CMO.S8103; Mardi K, Kaushal V, Sharma V. Rare coexistence of keratinizing squamous cell carcinoma with xanthogranulomatous pyelonephritis in the same kidney: report of two cases. J Cancer Res Ther. 2010;6(3):339-41. DOI:10.4103/0973-1482.73351; Lee TY, Ko SF, Wan YL, Cheng YF, Yang BY, Huang DL, Hsieh HH, Yu TJ, Chen WJ. Renal squamous cell carcinoma: CT findings and clinical significance. Abdom Imaging. 1998;23(2):203-8. DOI:10.1007/s002619900324; Kato T, Chabata T, Kazuta M. [A case of squamous cell carcinoma of the renal pelvis associated with staghorn stone]. Hinyokika Kiyo. 1966;12(1):43-6. (In Japanese). PMID: 5950233; Reddy DB, Rao N, Venkateswararao K, Venkateswararao N. Squamous cell carcinoma of the renal pelvis. Associated with the calculus of the kidney. (A study of four cases with review of literature). Indian J Cancer. 1969;6(1):27-33. PMID: 5795300; GAHAGAN HQ, REED WK. Squamous cell carcinoma of the renal pelvis; three case reports and review of the literature. J Urol. 1949;62(2):139-51. DOI:10.1016/s0022-5347(17)68899-2; O'HEERON MK. Report of a case of squamous carcinoma of the renal pelvis. Med Rec Ann. 1946;40:1409-11. PMID: 21027962; Chaurasia Z, Agarwal S, Gupta R, Khatana PS. Pelvicalyceal Squamous Cell Carcinoma: Incidental Diagnosis With Liver Metastasis on Follow Up. Cureus. 2021;13(9):e18345. DOI:10.7759/cureus.18345; Imbriaco M, Iodice D, Erra P, Terlizzi A, Di Carlo R, Di Vito C, Imbimbo C. Squamous cell carcinoma within a horseshoe kidney with associated renal stones detected by computed tomography and magnetic resonance imaging. Urology. 2011;78(1):54-5. DOI:10.1016/j.urology.2010.06.006; Nakamura Y, Tokunaga S, Ito H, Ikeda D, Ohkawa M, Namiki M, Takasawa K, Yokoyama H, Kobayashi K. [Squamous cell carcinoma of the renal pelvis associated with renal stones in a patient with chronic renal failure: a case report and a review of the Japanese literature]. Hinyokika Kiyo. 1996;42(6):451-5. (In Japanese). PMID: 8741302; Katz R, Gofrit ON, Golijanin D, Landau EH, Shapiro A, Pode D, Meretyk S. Urothelial cancer of the renal pelvis in percutaneous nephrolithotomy patients. Urol Int. 2005;75(1):17-20. DOI:10.1159/000085921; Jain A, Mittal D, Jindal A, Solanki R, Khatri S, Parikh A, Yadav K. Incidentally detected squamous cell carcinoma of renal pelvis in patients with staghorn calculi: case series with review of the literature. ISRN Oncol. 2011;2011:620574. DOI:10.5402/2011/620574; Sivaramakrishna B, Aron M, Ansari MS, Seth A, Goel R, Mundada OP, Balchander. Squamous cell carcinoma of the renal pelvis manifesting after percutaneous nephrolithotomy for long standing calculus. Int Urol Nephrol. 2004;36(2):149-51. DOI:10.1023/b:urol.0000034672.68658.fa; Li MK, Cheung WL. Squamous cell carcinoma of the renal pelvis. J Urol. 1987;138(2):269-71. DOI:10.1016/s0022-5347(17)43116-8; Di Battista L, Stio F, Guarino S, Galani A, Maturo A, Dimko M, Mancini M, Gallo P. Squamous cell carcinoma of the renal pelvis with stones and inferior vena cava infiltration. Case report. G Chir. 2012;33(5):182-5. PMID: 22709456; Balzer O, Böthig R, Schöps W, Thietje R, Soave A, Kadhum T, Golka K. Squamous cell carcinoma of the renal pelvis in a patient with long-term spinal cord injury-a case report. Spinal Cord Ser Cases. 2021;7(1):102. DOI:10.1038/s41394-021-00466-7; Ham BK, Kim JW, Yoon JH, Oh M, Bae JH, Park HS, Moon du G. Squamous cell carcinoma must be considered in patients with long standing upper ureteral stone and pyonephrosis. Urol Res. 2012;40(4):425-8. DOI:10.1007/s00240-011-0444-0; Hosseinzadeh M, Mohammadzadeh S. Primary Pure Squamous Cell Carcinoma of Kidney Associated with Multiple Stag Horn Stones. Int Med Case Rep J. 2020;13:261-263. DOI:10.2147/IMCRJ.S261022; Blacher EJ, Johnson DE, Abdul-Karim FW, Ayala AG. Squamous cell carcinoma of renal pelvis. Urology. 1985;25(2):124-6. DOI:10.1016/0090-4295(85)90526-6; Sun X, Li Y. Incidental squamous cell carcinoma of renal pelvis presenting as skin invasion: a case report. J Med Case Rep. 2020;14(1):244. DOI:10.1186/s13256-020-02530-6; Kim JR, Jeong YB, Lee NH, Wang SI. Squamous cell carcinoma of the renal pelvis presenting as an integumentary neoplasm of the flank: A case report. Medicine (Baltimore). 2019;98(36):e17049. DOI:10.1097/MD.0000000000017049; https://www.urovest.ru/jour/article/view/732
-
15Academic Journal
Authors: D. V. Perlin, I. N. Dymkov, A. V. Terentyev, A. D. Perlina, I. V. Alexandrov, Д. В. Перлин, И. Н. Дымков, А. В. Терентьев, А. Д. Перлина, И. В. Александров
Source: Transplantologiya. The Russian Journal of Transplantation; Том 15, № 1 (2023); 61-71 ; Трансплантология; Том 15, № 1 (2023); 61-71 ; 2542-0909 ; 2074-0506 ; undefined
Subject Terms: лапароскопическая донорская нефрэктомия, kidney transplantation, laparoscopic donor nephrectomy, трансплантация почки
File Description: application/pdf
Relation: https://www.jtransplantologiya.ru/jour/article/view/745/754; https://www.jtransplantologiya.ru/jour/article/view/745/768; Dols LF, Kok NF, Ijzermans JN. Live donor nephrectomy: a review of evidence for surgical techniques. Transpl Int. 2010;23(2):121–130. PMID: 20003169 https://doi.org/10.1111/j.1432-2277.2009.01027.x; Lee LY, Pham TA, Melcher ML. Living kidney donation: strategies to increase the donor pool. Surg Clin North Am. 2019;99(1):37–47. PMID: 30471740 https://doi.org/10.1016/j.suc.2018.09.003; Hart A, Smith JM, Skeans MA, Gustafson SK, Wilk AR, Robinson A, et al. OPTN/SRTR 2016 Annual Data Report: Kidney. Am J Transplant. 2018;18(Suppl 1):18–113. PMID: 29292608 https://doi.org/10.1111/ajt.14557; Creta M, Calogero A, Sagnelli C, Peluso G, Incollingo P, Candida M, et al. Donor and recipient outcomes following robotic-assisted laparoscopic living donor nephrectomy: a systematic review. Biomed Res Int. 2019;2019:1729138. PMID: 31143770 https://doi.org/10.1155/2019/1729138; Calogero A, Sagnelli C, Peluso G, Sica A, Candida M, Campanile S, et al. Physical activity in elderly kidney transplant patients with multiple renal arteries. Minerva Med. 2022;113(1):119–127. PMID: 32338484 https://doi.org/10.23736/S0026-4806.20.06573-8; Hamano I, Hatakeyama S, Fujita T, Murakami R, Hamaya T, Togashi K, et al. Living kidney transplantation from marginal donors presents feasible donor renal function despite inferior recipient renal function. Transplant Proc. 2020;52(6):1723–1728. PMID: 32448670 https://doi.org/10.1016/j.transproceed.2020.01.157; Devasia A, Chacko N, Gnanaraj L, Cherian R, Gopalakrishnan G. Stone-bearing live-donor kidneys for transplantation. BJU Int. 2005;95(3):394–397. PMID: 15679801 https://doi.org/10.1111/j.1464-410X.2005.05307.x; Barki A, Mhanna T, Aynaou M, Chennoufi M, Boateng PD, Houmaidi AE. Ex Vivo treatment of stones in living donor kidney by flexible ureteroscopy: time challenge (case report). Urol Case Rep. 2020;31:101178. PMID: 32322513 https://doi.org/10.1016/j.eucr.2020.101178; Vasdev N, Moir J, Dosani MT, Williams R, Soomro N, Talbot D, et al. Endourological management of urolithiasis in donor kidneys prior to renal transplant. ISRN Urol. 2011;2011:242690. PMID: 22084792 https://doi.org/10.5402/2011/242690; Lin CH, Zhang ZF, Wang J, Yu LX, Wang WT, Shi L, et al. Application of ureterorenoscope and flexible ureterorenoscope lithotripsy in removing calculus from extracorporeal living donor renal graft: a single-center experience. Ren Fail. 2017;39(1):561–565. PMID: 28726586 https://doi.org/10.1080/0886022X.2017.1349674; Sarier M, Duman I, Yuksel Y, Tekin S, Ozer M, Yucetin L, et al. Ex vivo stone surgery in donor kidneys at renal transplantation. Int J Urol. 2018;25(10):844–847. PMID: 30027658 https://doi.org/10.1111/iju.13755; A report of the Amsterdam forum on the care of the live kidney donor. Transplantation. 2005;79(6 Suppl):S53–S66. PMID: 15785361 https://doi.org/10.1097/01.tp.0000157343.27949.9f; Olsburgh J, Thomas K, Wong K, Bultitude M, Glass J, Rottenberg G, et al. Incidental renal stones in potential live kidney donors: prevalence, assessment and donation, including role of ex vivo ureteroscopy. BJU Int. 2013;111(5):784–792. PMID: 23110544 https://doi.org/10.1111/j.1464-410X.2012.11572.x; Rashid MG, Konnak JW, Wolf JS Jr, Punch JD, Magee JC, Arenas JD, et al. Ex vivo ureteroscopic treatment of calculi in donor kidneys at renal transplantation. J Urol. 2004;171(1):58–60. PMID: 14665843 https://doi.org/10.1097/01.ju.0000101757.69344.de; Lim SY, Kim MG, Park KT, Jung CW. Experiences of renal transplants from donors with renal cell carcinoma after ex vivo partial nephrectomy. Ann Surg Treat Res. 2017;92(5):361–364. PMID: 28480182 https://doi.org/10.4174/astr.2017.92.5.361; Schiavina R, Mari A, Antonelli A, Bertolo R, Bianchi G, Borghesi, et al. A snapshot of nephron-sparing surgery in Italy: a prospective, multicenter report on clinical and perioperative outcomes (the RECORd 1 project). Eur J Surg Oncol. 2015;41(3):346–352. PMID: 25583459 https://doi.org/10.1016/j.ejso.2014.12.001; Rizkala E, Coleman S, Tran C, Isac W, Flechner SM, Goldfarb D, et al. Stone disease in living-related renal donors: long-term outcomes for transplant donors and recipients. J Endourol. 2013;27(12):1520–1524. PMID: 24261656 https://doi.org/10.1089/end.2013.0203; Kasiske BL, Ravenscraft M, Ramos EL, Gaston RS, Bia MJ, Danovitch GM. The evaluation of living renal transplant donors: clinical practice guidelines. Ad Hoc Clinical Practice Guidelines Subcommittee of the Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol. 1996;7(11):2288–2313. PMID: 8959619 https://doi.org/10.1681/ASN.V7112288; Harraz AM, Kamal AI, Shokeir AA. Urolithiasis in renal transplant donors and recipients: an update. Int J Surg. 2016;36(Pt D):693–697. PMID: 27856353 https://doi.org/10.1016/j.ijsu.2016.11.032; Kamal AI, Harraz AM, Shokeir AA. Controversies related to living kidney donors. Arab J Urol. 2011;9(4):225–233. PMID: 26579303 https://doi.org/10.1016/j.aju.2011.11.001; Brar A, Jindal RM, Abbott KC, Hurst FP, Salifu MO. Practice patterns in evaluation of living kidney donors in United Network for Organ Sharing-approved kidney transplant centers. Am J Nephrol. 2012;35(5):466–473. PMID: 22555113 https://doi.org/10.1159/000338450; Barone B, Crocetto F, Vitale R, Domenico DD, Caputo V, Romano F, et al. Retrograde intra renal surgery versus percutaneous nephrolithotomy for renal stones >2 cm. A systematic review and meta-analysis. Minerva Urol Nefrol. 2020;72(4):441–450. PMID: 32083423 https://doi.org/10.23736/S0393-2249.20.03721-2; Türk C, Neisius A, Petrik A, Seitz C, Skolarikos A, Thomas K. EAU guidelines on urolithiasis. 2020. Available at: https://endouroclinic.ru/media/file-galleries/xpbnya/Compilation-EAU-Guidelines-2020-with-cover.pdf [Accessed January 11, 2023].; Breda A, Budde K, Figueiredo A, Lledó García E, Olsburgh J, Regele H. EAU guidelines on renal transplantation. 2022. Available at: https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelineson-Renal-Transplantation-2022.pdf [Accessed January 11, 2023].; Martin G, Sundaram CP, Sharfuddin A, Govani M. Asymptomatic urolithiasis in living donor transplant kidneys: initial results. Urology. 2007;70(1):2–6. PMID: 17656194 https://doi.org/10.1016/j.urology.2007.01.105; Pushkar P, Agarwal A, Kumar S, Guleria S. Endourological management of live donors with urolithiasis at the time of donor nephrectomy: a single center experience. Int Urol Nephrol. 2015;47(7):1123-1127. PMID: 25987343 https://doi.org/10.1007/s11255-015-1007-z; Ganpule A, Vyas JB, Sheladia C, Mishra S, Ganpule SA, Sabnis RB, et al. Management of urolithiasis in liverelated kidney donors. J Endourol. 2013;27(2):245–250. PMID: 22973987 https://doi.org/10.1089/end.2012.0320; Longo N, Calogero A, Creta M, Celentano G, Napolitano L, Capece M, et al. Outcomes of renal stone surgery performed either as predonation or ex vivo bench procedure in renal grafts from living donors: a systematic review. Biomed Res Int. 2020;2020:6625882. PMID: 33335926 https://doi.org/10.1155/2020/6625882; Yiğit B, Aydin C, Titiz I, Berber I, Sinanoğlu O, Altaca G. Stone disease in kidney transplantation. Transplant Proc. 2004;36(1):187–189. PMID: 15013342 https://doi.org/10.1016/j.transproceed.2003.11.063; Schade GR, Wolf JS, Faerber GJ. Ex-vivo ureteroscopy at the time of live donor nephrectomy. J Endourol. 2011;25(9):1405–1409. PMID: 21711138 https://doi.org/10.1089/end.2010.0627; https://www.jtransplantologiya.ru/jour/article/view/745
-
16Academic Journal
Authors: K. V. Pozdnyakov, S. A. Rakul, R. A. Eloev, K. A. Lukinov, К. В. Поздняков, С. А. Ракул, Р. А. Елоев, К. А. Лукинов
Source: Cancer Urology; Том 19, № 3 (2023); 19-28 ; Онкоурология; Том 19, № 3 (2023); 19-28 ; 1996-1812 ; 1726-9776
Subject Terms: острое почечное повреждение, partial nephrectomy, radical nephrectomy, acute kidney injury, резекция почки, радикальная нефрэктомия
File Description: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/1594/1476; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1594/1175; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1594/1176; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1594/1177; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1594/1178; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1594/1179; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1594/1180; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1594/1181; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1594/1182; Аксель Е.М., Матвеев В.Б. Статистика злокачественных новообразований мочевых и мужских половых органов в России и странах бывшего СССР. Онкоурология 2019;15(2):15–24. DOI:10.17650/1726-9776-2019-15-2-15-24; Ljungberg B., Bensalah K., Canfield S. et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 2015;67(5):913–24. DOI:10.1016/j.eururo.2015.01.005; Campbell S., Uzzo R.G., Allaf M.E. et al. Renal mass and localized renal cancer: AUA guideline. J Urol 2017;198(3):520–9. DOI:10.1016/j.juro.2017.04.100; Ракул С.А., Поздняков К.В., Елоев Р.А. Отдаленные онкологические результаты хирургического лечения локализованных опухолей почек. Онкоурология 2021;17(4):27–37. DOI:10.17650/1726-9776-2021-17-4-27-37; Kim S.P., Campbell S.C., Gill I. et al. Collaborative review of risk benefit trade-offs between partial and radical nephrectomy in the management of anatomically complex renal masses. Eur Urol 2017;72(1):64–75. DOI:10.1016/j.eururo.2016.11.038; Kim S.P., Thompson R.H., Boorjian S.A. et al. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol 2012;188(1):51–7. DOI:10.1016/j.juro.2012.03.006; Соколов Д.В., Полушин Ю.С. Острое почечное повреждение в периоперационном периоде. Вестник анестезиологии и реаниматологии 2018;15(1):46–54. DOI:10.21292/2078-5658-2018-15-1-46-54; Chawla L.S., Eggers P.W., Star R.A. et al. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 2014;371(1):58–66. DOI:10.1056/NEJMra1214243; Bellomo R., Ronco C., Kellum J.A. et al. Acute Dialysis Quality Initiative workgroup. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8(4):204–12. DOI:10.1186/cc2872; Mehta R.L., Kellum J.A., Shah S.V. et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11(2):31. DOI:10.1186/cc5713; Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012;120(4):179–84. DOI:10.1159/000339789; Thomas A.A., Demirjian S., Lane B.R. et al. Acute kidney injury: novel biomarkers and potential utility for patient care in urology. Urology 2011;77(1):5–11. DOI:10.1016/j.urology.2010.05.004; Thompson R.H., Lane B.R., Lohse CM. et al. Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. Urology 2012;79(2):356–60. DOI:10.1016/j.urology.2011.10.031; Lane B.R., Russo P., Uzzo R.G. et al. Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function. J Urol 2011;185(2):421–7. DOI:10.1016/j.juro.2010.09.131; Zhang Z., Zhao J., Dong W. et al. Acute kidney injury after partial nephrectomy: role of parenchymal mass reduction and ischemia and impact on subsequent functional recovery. Eur Urol 2016;69(4): 745–52. DOI:10.1016/j.eururo.2015.10.023; National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;9(2 Suppl 1):1–266.; Bravi C.A., Vertosick E., Benfante N. et al. Impact of acute kidney injury and its duration on long-term renal function after partial nephrectomy. Eur Urol 2019;76(3):398–403. DOI:10.1016/j.eururo.2019.04.040; Suer E., Akpinar C., Izol V. et al. Predicting factors of acute kidney injury after partial nephrectomy and its impact on long-term renal function: a multicentre study of the Turkish Urooncology Association. Int J Clin Pract 2021;75(11). DOI:10.1111/ijcp.14751; Zhu K., Song H., Zhang Z. et al. Acute kidney injury in solitary kidney patients after partial nephrectomy: incidence, risk factors and prediction. Transl Androl Urol 2020;9(3):1232–43. DOI:10.21037/tau.2020.03.45; Volpe A., Blute M.L., Ficarra V. et al. Renal ischemia and function after partial nephrectomy: a collaborative review of the literature. Eur Urol 2015;68(1):61–74. DOI:10.1016/j.eururo.2015.01.025; Parekh D.J., Weinberg J.M., Ercole B. et al. Tolerance of the human kidney to isolated controlled ischemia. J Am Soc Nephrol 2013;24(3):506–17. DOI:10.1681/ASN.2012080786; Wahlberg E., Di Muzio P.J., Stoney R.J. et al. Aortic clamping during elective operations for infrarenal disease: the influence of clamping time on renal function. J Vasc Surg 2002;36(1):13–8. DOI:10.1067/mva.2002.123679; Xiong L., Nguyen J.K., Peng Y. et al. What happens to the preserved renal parenchyma after clamped partial nephrectomy? Eur Urol 2022;81(5):492–500. DOI:10.1016/j.eururo.2021.12.036; Antonelli A., Cindolo L., Sandri M. et al. Is off-clamp robot-assisted partial nephrectomy beneficial for renal function? Data from the CLOCK trial. BJU Int 2022;129(2):217–24. DOI:10.1111/bju.15503; Zabell J., Isharwal S., Dong W. et al. Acute kidney injury after partial nephrectomy of solitary kidneys: impact on long-term stability of renal function. J Urol 2018;200(6):1295–301. DOI:10.1016/j.juro.2018.07.042; Kim N.Y., Hong J.H., Koh D.H. et al. Effect of diabetes mellitus on acute kidney injury after minimally invasive partial nephrectomy: a case-matched retrospective analysis. J Clin Med 2019;8(4):468. DOI:10.3390/jcm8040468; https://oncourology.abvpress.ru/oncur/article/view/1594
-
17Academic Journal
Authors: V. R. Latypov, V. S. Popov, V. N. Latypova, S. I. Novikov, D. B. Akhmedov, O. S. Zebzeeva, В. Р. Латыпов, О. С. Попов, В. Н. Латыпова, С. И. Новиков, Д. Б. Ахмедов, О. С. Зебзеева
Contributors: The study was performed without external funding., Исследование проведено без спонсорской поддержки.
Source: Cancer Urology; Том 18, № 4 (2022); 25-32 ; Онкоурология; Том 18, № 4 (2022); 25-32 ; 1996-1812 ; 1726-9776
Subject Terms: удаление тромба нижней полой вены, kidney resection, radical nephrectomy, inferior vena cava thrombus, inferior vena cava thrombus removal, резекция почки, радикальная нефрэктомия, тромб нижней полой вены
File Description: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/1491/1413; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1491/1027; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1491/1028; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1491/1029; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1491/1030; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1491/1031; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1491/1032; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1491/1033; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1491/1034; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1491/1035; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1491/1036; Клиническая онкоурология. Под ред. Б.П. Матвеева. М.: АБВ-пресс, 2011.; Chen W., Zheng R., Baade P.D. et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016;66(2):115–32. DOI:10.3322/caac.21338; Hötker A.M., Karlo C.A., Zheng J. et al. Clear cell renal cell carcinoma: associations between CT features and patient survival. AJR Am J Roentgenol 2016;206(5):1023–30. DOI:10.2214/AJR.15.15369; Rini B.I., Campbell S.C., Escudier B. Renal cell carcinoma. Lancet 2009;373(9669):1119–32. DOI:10.1016/S0140-6736(09)60229-4; Mirza М. Management of small renal masses in the older adult. Clin Geriatr Med 2015;31(4):603–13. DOI:10.1016/j.cger.2015.06.005; Guidelines. European Association of Urology, 2020.; Матвеев В.Б., Маркова А.С. Рак почки: что нового в 2018 году. Онкоурология 2018;14(4):48–52. DOI:10.17650/1726-9776-2018-14-4-48-52; Humphrey P.A., Moch H., Cubilla A.L. et al. The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours. Eur Urol 2016;70(1):106–19. DOI:10.1016/j.eururo.2016.02.028; Liungberg B., Bensalah K., Canfield S. et al. EAU guidelines on renal cell carcinoma. Eur Urol 2015;67(5):913–24. DOI:10.1016/j.eururo.2015.01.005; Щукин Д.В., Илюхин Ю.А. Хирургия опухолевых тромбов нижней полой вены при раке почки. Белгород: Белгородская областная типография, 2007. 196 c.; Diagnosis and surgical management of renal tumors. Eds.: M.A. Gorin, M.E. Allaf. Springer International Publishing AG, part of Springer Nature, 2019.; Hsieh J.J., Purdue M.P., Signoretti S. et al. Renal cell carcinoma Nat Rev Dis Primers 2017;3:17009. DOI:10.1038/nrdp.2017.9; Jakubovskis M., Kojalo U., Steinbrekera B. et al. Renal cell carcinoma trends in Latvia: incidence, mortality, and survival rates. Population-based study. Cent European J Urol 2019;72(4):344–50. DOI:10.5173/ceju.2019.0018; Reix B., Bernhard J.C., Patard J.J. et al. Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: a collaborative international study from the French kidney cancer research network UroCCR. Prog Urol 2018;28(3):146–55. DOI:10.1016/j.purol.2017.12.004; Давыдов М.И., Матвеев В.Б., Матвеев Б.П. Операции на нижней полой вене у больных раком почки. Материалы VI Российской онкологической конференции. Доступно по: http://www.rosoncoweb.ru/library/congress/ru/06/21.php.; Переверзев А.С. Хирургия опухолей почки и верхних мочевых путей. Харьков: Lora Medpharm, 1997. 392 c.; Lambert E.H., Pierorazio P.M., Shabsigh A. et al. Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus. Urology 2007;69(6):1054–8. DOI:10.1016/j.urology.2007.02.052; Gonzalez J., Gorin M.A., Garcia-Roig M., Ciancio G. Inferior vena cava resection and reconstruction: technical considerations in the surgical management of renal cell carcinoma with tumor thrombus. Urol Oncol 2014;32(1):34.e19–26. DOI:10.1016/j.urolonc.2013.01.004; Волкова М.И., Черняев В.А., Бегалиев А.К. и др. Безопасность перевязки левой почечной вены во время циркулярной резекции нижней полой вены у больных раком правой почки с опухолевым венозным тромбозом. Онкоурология 2018;14(4):30–6. DOI:10.17650/1726-9776-2018-14-4-30-36; Котов С.В., Кириенко А.И., Юсуфов А.Г. и др. Интраоперационные и онкологические результаты лечения пациентов с почечно-клеточным раком и распространением опухолевого тромба по венозной системе. Онкоурология 2018;14(1):57–67. DOI:10.17650/1726-9776-2018-14-1-57-67; https://oncourology.abvpress.ru/oncur/article/view/1491
-
18Academic Journal
Authors: D. V. Semenov, R. V. Orlova, V. I. Shirokorad, S. V. Kostritskiy, M. I. Gluzman, Yu. S. Korneva, Д. В. Семенов, Р. В. Орлова, В. И. Широкорад, С. В. Кострицкий, М. И. Глузман, Ю. С. Корнева
Source: Cancer Urology; Том 19, № 3 (2023); 31-44 ; Онкоурология; Том 19, № 3 (2023); 31-44 ; 1996-1812 ; 1726-9776
Subject Terms: системная терапия, cytoreductive nephrectomy, overall survival, IMDC risk group, systemic therapy, циторедуктивная нефрэктомия, общая выживаемость, группа прогноза по IMDC
File Description: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/1687/1477; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1687/1310; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1687/1311; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1687/1312; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1687/1313; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1687/1314; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1687/1315; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1687/1316; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1687/1317; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1687/1318; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1687/1319; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1687/1320; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1687/1321; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1687/1322; Capitanio U., Bensalah K., Bex A. et al. Epidemiology of renal cell carcinoma. Eur Urol 2019;75(1):74-84. DOI:10.1016/j.eururo.2018.08.036; Ljungberg B., Albiges L., Abu-Ghanem Y. et al. European Association of Urology guidelines on renal cell carcinoma: the 2019 update. Eur Urol 2019;75(5):799-810. DOI:10.1016/j.eururo.2019.02.011; Flanigan R.C., Salmon S.E., Blumenstein B.A. et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 2001;345(23):1655-9. DOI:10.1056/NEJMoa003013; Mickisch G.H., Garin A., van Poppel H. et al. European Organisation for Research and Treatment of Cancer (EORTC) Genitourinary Group. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 2001;358(9286):966-70. DOI:10.1016/s0140-6736(01)06103-7; Flanigan R.C., Mickisch G., Sylvester R. et al. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol 2004;171(3):1071-6. DOI:10.1097/01.ju.0000110610.61545.ae; Heng D.Y., Wells J.C., Rini B.I. et al. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol 2014;66(4):704-10. DOI:10.1016/j.eururo.2014.05.034; Mejean A., Ravaud A., Thezenas S. et al. Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma. N Engl J Med 2018;379(5):417-27. DOI:10.1056/NEJMoa1803675; Bex A., Mulders P., Jewett M. et al. Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME randomized clinical trial. JAMA Oncol 2019;5(2):164-70. DOI:10.1001/jamaoncol.2018.5543; Motzer R.J., Jonasch E., Michaelson M.D. et al. NCCN Guidelines Insights: kidney cancer, version 2.2020. J Natl Compr Canc Netw 2019;17(11):1278-85. DOI:10.6004/jnccn.2019.0054; Xiao W.J., Zhu Y., Dai B. et al. Assessment of survival of patients with metastatic clear cell renal cell carcinoma after radical cytoreductive nephrectomy versus no surgery: a SEER analysis. Int Braz J Urol 2015;41(2):288-95. DOI:10.1590/s1677-5538.IBJU.2015.02.15; Hanna N., Sun M., Meyer C.P. et al. Survival analyses of patients with metastatic renal cancer treated with targeted therapy with or without cytoreductive nephrectomy: a National Cancer Data Base study. J Clin Oncol 2016;34(27):3267-75. DOI:10.1200/JCO.2016.66.7931; Arora S., Sood A., Dalela D. et al. Cytoreductive nephrectomy: assessing the generalizability of the CARMENA trial to real-world national cancer data base cases. Eur Urol 2019;75(2):352-3. DOI:10.1016/j.eururo.2018.10.054; Bhindi B., Abel E.J., Albiges L. et al. Systematic review of the role of cytoreductive nephrectomy in the targeted therapy era and beyond: an individualized approach to metastatic renal cell carcinoma. Eur Urol 2019;75(1):111-28. DOI:10.1016/j.eururo.2018.09.016; Singla N., Hutchinson R.C., Ghandour R.A. et al. Improved survival after cytoreductive nephrectomy for metastatic renal cell carcinoma in the contemporary immunotherapy era: an analysis of the National Cancer Database. Urol Oncol 2020;38(6):604.e9-17. DOI:10.1016/j.urolonc.2020.02.029; I.N. Group SO. Comparing the outcome of immunotherapy-based drug combination therapy with or without surgery to remove the kidney in metastatic kidney cancer, the PROBE trial (PROBE).; Deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: The NORDIC-SUN-Trial (NORDIC-SUN). Sponsor: Donskov F., Aarhus University Hospital. DOI:10.31525/ct1-nct03977571; Mejean A., Ravaud A., Thezenas S. et al. Sunitinib alone or after nephrectomy for patients with metastatic renal cell carcinoma: is there still a role for cytoreductive nephrectomy? Eur Urol 2021;80(4):417-24. DOI:10.1016/j.eururo.2021.06.009; Kato R., Naito S., Numakura K. et al. Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective study. Int J Clin Oncol 2022;27(3):563-73. DOI:10.1007/s10147-021-02091-8; Esagian S.M., Ziogas I.A., Kosmidis D. et al. Long-term survival outcomes of cytoreductive nephrectomy combined with targeted therapy for metastatic renal cell carcinoma: a systematic review and individual patient data meta-analysis. Cancers (Basel) 2021;13(4):695. DOI:10.3390/cancers13040695; Bhindi B., Graham J., Wells J.C. et al. Deferred cytoreductive nephrectomy in patients with newly diagnosed metastatic renal cell carcinoma. Eur Urol 2020;78(4):615-23. DOI:10.1016/j.eururo.2020.04.038; De Bruijn R., Wimalasingham A., Szabados B. et al. Deferred cytoreductive nephrectomy following presurgical vascular endothelial growth factor receptor-targeted therapy in patients with primary metastatic clear cell renal cell carcinoma: a pooled analysis of prospective trial data. Eur Urol Oncol 2020;3(2):168-73. DOI:10.1016/j.euo.2019.12.004; Bakouny Z., El Zarif T., Dudani S. et al. Upfront cytoreductive nephrectomy for metastatic renal cell carcinoma treated with immune checkpoint inhibitors or targeted therapy: an observational study from the international metastatic renal cell carcinoma database consortium. Eur Urol 2022;83(2):145-51. DOI:10.1016/j.eururo.2022.10.004; Westerman M.E., Shapiro D.D., Tannir N.M. et al. Survival following cytoreductive nephrectomy: a comparison of existing prognostic models. BJU Int 2020;126(6):745-53. DOI:10.1111/bju.15160; Mori K., Quhal F., Yanagisawa T. et al. The effect of immune checkpoint inhibitor combination therapies in metastatic renal cell carcinoma patients with and without previous cytoreductive nephrectomy: a systematic review and meta-analysis. Int Immunopharmacol 2022;108:10872. DOI:10.1016/j.intimp.2022.108720; https://oncourology.abvpress.ru/oncur/article/view/1687
-
19Academic Journal
Authors: B. G. Guliev, Б. Г. Гулиев
Source: Cancer Urology; Том 19, № 1 (2023); 37-45 ; Онкоурология; Том 19, № 1 (2023); 37-45 ; 1996-1812 ; 1726-9776
Subject Terms: повторная резекция почки, tumor recurrence, kidney resection, partial nephrectomy, Da Vinci robot, robot-assisted kidney resection, repeat tumor resection, рецидив опухоли, резекция почки, парциальная нефрэктомия, робот Da Vinci, робот-ассистированная резекция почки
File Description: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/1629/1435; Maurice M.J., Zhu H., Kim S.P., Abouassaly R. Increased use of partial nephrectomy to treat high-risk disease. BJU Int 2016;117(6):75-86. DOI:10.1111/bju.13262; Mir M.C., Derweesh I., Porpiglia F. et al. Partial nephrectomy versus radical nephrectomy for clinical T1b and T2 renal tumors: A systematic review and meta-analysis of comparative studies. Eur Urol 2017;71(4):606-17. DOI:10.1016/j.eururo.2016.08.060; Волкова М.И., Ридин В.А., Черняев В.А. и др. Нужна ли технически сложная резекция больным опухолями почечной паренхимы с нормальной контралатеральной почкой? Онкоурология 2019;15(4):39-49. DOI:10.17560/1726-9776-2019-15-4-39-49; Shah P.H., Moreira D.M., Okhunov Z. et al. Positive surgical margin increase risk of recurrence after partial nephrectomy for high risk renal tumors. J Urol 2016;196(2):327-34. DOI:10.1016/j.juro.2016.02.075; Muhlbauer J., Kowalewski K.F., Walach M.T. et al. Partial nephrectomy preserves renal function without increasing the risk of complications compared with radical nephrectomy for renal cell carcinoma of stages pT2-3a. Int J Urol 2020;27(10):906-13. DOI:10.1111/iju.14326; Hamilton Z.A., Capitano U., Pruthi D. et al. Risk factors for upstaging, recurrence and mortality in clinical T1-2 renal cell carcinoma patients upstaged to pT3 disease: an international analysis utilizing the 8th edition of the tumor-node-metastasis staging criteria. Urology 2020;138:60-8. DOI:10.1016/j.urology.2019.11.036; Mouracade P., Kara O., Maurice M.J. et al. Patterns and predictors of recurrence after partial nephrectomy for kidney tumors. J Urol 2017;197(6):1403-9. DOI:10.1016/j.juro.2016.12.046; Salkini M.W., Idris N., Lamoshi A.R. The incidence and pattern of renal cell carcinoma recurrence after robotic partial nephrectomy. Urol Annal 2019;11(4):353-7. DOI:10.4103/UA.UA_134_18; Wood E.L., Adibi M., Qiao W. et al. Local tumor bed recurrence following partial nephrectomy in patients with small renal masses. J Urol 2018;199(2):393-400. DOI:10.1016/j.juro.2017.09.072; Kriegmair M.C., Bertolo R., Karakiewicz P.I. et al. Systematic review of the management of local kidney cancer relapse. Eur Urol Oncol 2018;1(6):512-23. DOI:10.1016/j.euo.2018.06.007; Shuch B., Linehan W.M., Bratslavsky G. Repeat partial nephrectomy: surgical, functional and oncological outcomes. Curr Opin Urol 2011;21(5):368-75. DOI:10.1097/MOU.0b013e32834964ea; Johnson A., Sudarshan S., Liu J. et al. Feasibility and outcomes of repeat partial nephrectomy. J Urol 2008;180(1):89-93. DOI:10.1016/j.juro.2008.03.030; Liu N.W., Khurana K., Sudarshan S. et al. Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes. J Urol 2010;183(5):1719-24. DOI:10.1016/j.juro.2010.01.010; Watson M., Sidana A., Walton Diaz A. et al. Repeat robotic partial nephrectomy: characteristics, complications and renal functional outcomes. J Endourol 2016;30(11):1219-26. DOI:10.1089/end.2016.0517; Ракул С.А., Поздняков К.В., Елоев Р.А. Органосохраняющие операции при сложных опухолях почек. Урология 2020;(6):99-105. DOI:10.18565/urology.2020.6.99-105; Гулиев Б.Г., Комяков Б.К., Ягубов X.X. Робот-ассистированная парциальная нефрэктомия с селективной ишемией. Урология 2022;(1):55-60. DOI:10.10565/urology.2022.1-55-60; Magera J.S., Frank I., Lohse C.M. et al. Analysis of repeat nephron sparing surgery as a treatment option in patients with a solid mass in a renal remnant. J Urol 2008;179(3):853-6. DOI:10.1016/j.juro.2007.10.049; Bratslavsky G., Liu J.J., Johnson A.D. et al. Salvage partial nephrectomy for hereditary renal cancer: Feasibility and outcomes. J Urol 2008;179(1):67-70. DOI:10.1016/j.juro.2007.08.150; Kowalczyk K.J., Hooper H.B., Linehan W.M. et al. Partial nephrectomy after previous radio frequency ablation: the National Cancer Institute experience. J Urol 2009;182(5):2158-63. DOI:10.1016/j.juro.2009.07.064; Yoshida K., Kondo T., Takagi T. et al. Clinical outcomes of repeat partial nephrectomy compared to initial partial nephrectomy of a solitary kidney. Int J Clin Oncol 2020;25(6):1155—62. DOI:10.1007/s10147-020-01633-w; Autorino R., Khalifeh A., Laydner H. et al. Repeat robot-assisted partial nephrectomy: feasibility and early outcomes. BJU Int 2013;111(5):767-72. DOI:10.1111/j.1464-4108.2013.11800.x; Jain S., Yates J.K. Robot-assisted laparoscopic partial nephrectomy for recurrent renal-cell carcinoma in patients previously treated with nephron-sparing surgery. J Endourol 2013;27(3):309-12. DOI:10.1089/end.2012.0184; Martini A., Turri F., Barod R. et al. Surgery for local recurrence after surgical resection or renal mass ablation: classification, techniques and clinical results. Eur Urol 2021;80(6):730-7. DOI:10.1016/j.eururo.2021.04.003; Gurram S., Friedberg N.A., Gordhan C. et al. Reoperative partial nephrectomy - does previous surgical footprint impact outcomes? J Urol 2021;206(3):539-47. DOI:10.1097/JU.0000000001837; https://oncourology.abvpress.ru/oncur/article/view/1629
-
20Academic Journal
Authors: O. M. Romantsova, V. Yu. Panarina, M. A. Bolokhonova, V. V. Khairullova, D. B. Khestanov, M. M. Efimova, T. R. Panferova, O. A. Ignatenko, N. A. Kozlov, A. M. Stroganova, K. I. Kirgizov, S. R. Varfolomeeva, О. М. Романцова, В. Ю. Панарина, М. А. Болохонова, В. В. Хайруллова, Д. Б. Хестанов, М. М. Ефимова, Т. Р. Панферова, О. А. Игнатенко, Н. А. Козлов, А. М. Строганова, К. И. Киргизов, С. Р. Варфоломеева
Source: Russian Journal of Pediatric Hematology and Oncology; Том 10, № 3 (2023); 70-81 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 10, № 3 (2023); 70-81 ; 2413-5496 ; 2311-1267
Subject Terms: аутологичная трансплантация гемопоэтических стволовых клеток, sarcoma kidney, chemotherapy, radiation therapy, nephrectomy, autologous hematopoietic stem cell transplantation, саркома Юинга почки, химиотерапия, лучевая терапия, нефрэктомия
File Description: application/pdf
Relation: https://journal.nodgo.org/jour/article/view/965/849; Zhang S., Li Y., Wang R., Song B. Ewing’s sarcoma/primitive neuroectodermal tumor of the kidney: a case report and literature review. Transl Androl Urol. 2019;8(5):562–6. doi:10.21037/tau.2019.09.46.; Ellinger J., Bastian P.J., Hauser S., Biermann K., Müller S.C. Primitive neuroectodermal tumor: Rare, highly aggressive diff erential diagnosis in urologic malignancies. Urology. 2006;68:257–62. doi:10.1016/j.urology.2006.02.037.; Seemayer T., Thelmo W., Bolande R. Peripheral neuroectodermal tumors. Perspect Pediatr Pathol. 1975;2:151–72. PMID: 1129029.; Романцова О.М., Хестанов Д.Б., Дзампаев А.З., Хайруллова В.В., Ефимова М.М., Горбунова Т.В., Киргизов К.И., Варфоломеева С.Р. Костная и внескелетная саркома Юинга: сравнительная характеристика особенностей течения и исходов заболевания (опыт НИИ детской онкологии и гематологии им. Л.А. Дурнова). Педиатрия. Журнал им. Г.Н. Сперанского. 2023;102(3):41–50. doi:10.24110/0031-403X-2023-102-3-41-50.; Choi J.H., Ro J.Y. The 2020 WHO Classification of Tumors of Soft Tissue: Selected Changes and New Entities Adv Anathomy Pathor. 2021;28(1):44–58. doi:10.1097/PAP.0000000000000284.; Welsch T., Mechtersheimer G., Aulmann S., Mueller S.A., Buechler M.W., Schmidt J., Kienle P. Huge primitive neuroectodermal tumor of the pancreas: Report of a case and review of the literature. World J Hastroenterol. 2006;12(37):6070–3. doi:10.3748/wjg.v12.i37.6070.; Нисиченко О.А., Долгополов И.С., Нисиченко Д.В., Малахова А.А., Романцова О.М., Хестанов Д.Б., Дзампаев А.З. Определение стратегии лечения детей и подростков с саркомой Юинга при первичном поражении костей таза. Саркомы костей, мягких тканей и опухоли кожи. 2020;12(2–3):45–53. doi:10.17650/2070-9781-2020-21-3-45-53.; Tarek N., Said R., Andersen C.R., Suki T.S., Foglesong J., Herzog C.E., Tannir N.M., Patel S., Ratan R., Ludwig J.A., Daw N.C. Primary Ewing Sarcoma Primitive Neoriectodermal Tumor of the Kidney: The MD Anderson Cancer Center Expirience Cancers (Basel), 2020. doi:10.3390/cancers12102927.; Cheng L., Xu Y., Song H., Huang H., Zhuo D. A rare entity of Primary Ewing sarcoma in kidney. BMC Surg. 2020;20(1):280. doi:10.1186/s12893-020-00948-9.; Alghamdi M.H.A., Alawad S.A., Alharbi M.G., Alabdulsalam A.K., Almodhen F., Alasker A. A rare case of Ewing’s sarcoma of the kidney. Urol Case Rep. 2019:29:101094. doi:10.1016/j.eucr.2019.101094.; Brown H.K., Schiavone K., Gouin F., Heymann M.F., Heymann D. Biology of Bone Sarcomas and New Therapeutic Developments. Calcif Tissue Int. 2018;102(2):174–95. doi:10.1007/s00223-017-0372-2.; Thyavihally Y.B., Tongaonkar H.B., Gupta S., Kurkure P.A., Amare P., Muckaden M.A., Desai S.B. Primitive Neuroectodermal Tumor of the Kidney: A Single Institute Series of 16 Patients. Urology. 2008;71:292–6. doi:10.1016/j.urology.2007.09.051.; Karpate A., Menon S., Basak R., Yuvaraja T.B., Tongaonkar H.B., Desai S.B. Ewing sarcoma/primitive neuroectodermal tumor of the kidney: Clinicopathologic analysis of 34 cases. Ann Diagn Pathol 2012;16:267–74. doi:10.1016/j.anndiagpath.2011.07.011.; Hakky T.S., Gonzalvo A.A., Lockhart J.L., Rodriguez A.R. Primary Ewing sarcoma of the kidney: A symptomatic presentation and review of the literature. Ther Adv Urol. 2012;5:153–9. doi:10.1177/1756287212471095.; Applebaum M.A., Worch J., Matthay K.K., Goldsby R., Neuhaus J., West D.C., Dubois S.G. Clinical features and outcomes in patients with extraskeletal ewing sarcoma. Cancer. 2011;117:3027–32. doi:10.1002/cncr.25840.; Miller R.W. Contrasting epidemiology of childhood osteosarcoma, Ewing’s tumor, and rhabdomyosarcoma. Natl Cancer Inst Monogr. 1981;56:9–15. PMID: 7029300.; Cotterill S., Ahrens S., Paulussen M., Jürgens H., Voûte P., Gadner H., Craft A. Prognostic Factors in Ewing’s Tumor of Bone: Analysis of 975 Patients from the European Intergroup Cooperative Ewing’s Sarcoma Study Group. J Clin Oncol. 2000;18:3108–14. doi:10.1200/JCO.2000.18.17.3108.; Rodriguez-Galindo C., Liu T., Krasin M.J., Wu J., Billups C.A., Daw N.C., Spunt S.L., Rao B.N., Santana V.M., Navid F. Analysis of prognostic factors in ewing sarcoma family of tumors. Cancer. 2007;110:375–84. doi:10.1002/cncr.22821.; Risi E., Iacovelli R., Altavilla A., Alesini D., Palazzo A., Mosillo C., Trenta P., Cortesi E. Clinical and Pathological Features of Primary Neuroectodermal Tumor/Ewing Sarcoma of the Kidney. Urology. 2013;82:382–6. doi:10.1016/j.urology.2013.04.015.; Rowe R.G., Thomas D., Schuetze S.M., Hafez K.S., Lawlor E.R., Chugh R. Ewing Sarcoma of the Kidney: Case Series and Literature Review of an Often Overlooked Entity in the Diagnosis of Primary Renal Tumors. Urololgy. 2013;81:347–53. doi:10.1016/j.urology.2012.10.016.; Zöllner S., Dirksen U., Jürgens H., Ranft A. Renal Ewing tumors. Ann Oncol. 2013;24:2455–61. doi:10.1093/annonc/mdt215.; Валиев Т.Т., Панферова Т.Р., Кошечкина Н.А., Захарова Е.В., Михайлова Е.В., Каминская И.В. Поражение почек при неходжкинских лимфомах у детей. Современная онкология. 2014;16(1):53–9.; Huang J., Zhang J., Dong B., Clien Y., Kong W., Liu Q. Primitive neuroectodermal tumor of the kidney: a single-institute series of six patients from China. Urol Int. 2013;90:174–8. doi:10.1159/000342647.; Rodriguez-Galindo C., Marina N.M., Fletcher B.D., Parham D.M., Bodner S.M., Meyer W.H. Is primitive neuroectodermal tumor of the kidney a distinct entity? Cancer. 1997;79:2243–50. doi:10.1002/(SICI)1097-0142(19970601)79:113.0.CO;2-V.; Grier H.E., Krailo M.D., Tarbell N.J., Link M.P., Fryer C.J.H., Pritchard D.J., Gebhardt M.C., Dickman P.S., Perlman E.J., Meyers P.A., Donaldson S.S., Moore S., Rausen A.R., Vietti T.J., Miser J.S. Addition of Ifosfamide and Etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003;348(8):694–701. doi:10.1056/NEJMoa020890.; Womer R.B., West D.C., Krailo M.D., Dickman P.S., Pawel B.R., Grier H.E., Marcus K., Sailer S., Healey J.H., Dormans J.P., Weiss A.R. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Childrenʼs Oncology Group. J Clin Oncol. 2012;30(33):4148–54. doi:10.1200/JCO.2011.41.5703.; Juergens C., Weston C., Lewis I., Whelan J., Paulussen M., Oberlin O., Michon J., Zoubek A., Juergens H., Craft A. Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EUROE.W.I.N.G. 99 clinical trial. Pediatr Blood Cancer. 2006;47(1):22–9. doi:10.1002/pbc.20820.; Wagner M.J., Ravi V., Livingston J.A., Conley A.P., Araujo D., Somaiah N., Zarzour M.A., Ratan R., Wang W.-L., Patel S.R., Lazar A., Ludwig J.A., Benjamin R.S. Vincristine, ifosfamide, and doxorubicin for initial treatment of Ewing sarcoma in adults. Oncologist. 2017;22(10):1271–7. doi:10.1634/theoncologist.2016-0464.; Chakrabarti N., Dewasi N., Das S., Bandyopadhyay A., Bhadure N. Primary Ewing’ s sarcoma/primitive neuroectodermal tumor of kidney – a diagnostic dilemma. Iran J Cancer Prev. 2015;8(2):129–33. PMID: 25960853.; Kuczynski A.P., Gugelmin E.S., Netto R.A.S. Primitive neuroectodermal tumor of the kidney in children. J Pediatia. 2001;77(1):49–51. doi:10.2223/JPED.111.; https://journal.nodgo.org/jour/article/view/965